Next Article in Journal
Novel Polycarbo-Substituted Imidazo[1,2-c]quinazolines: Synthesis and Cytotoxicity Study
Next Article in Special Issue
Synthesis of Some Novel 2-Amino-5-arylazothiazole Disperse Dyes for Dyeing Polyester Fabrics and Their Antimicrobial Activity
Previous Article in Journal
Green Chemistry Approach for Synthesis of Effective Anticancer Palladium Nanoparticles
Previous Article in Special Issue
Synthesis and Regioselective Reaction of Some Unsymmetrical Heterocyclic Chalcone Derivatives and Spiro Heterocyclic Compounds as Antibacterial Agents
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Syntheses of 4-Indolylquinoline Derivatives via Reductive Cyclization of Indolylnitrochalcone Derivatives by Fe/HCl

Department of Chemistry, National Taiwan Normal University, 88, Sec. 4, Ting-Chow Road, Taipei 116, Taiwan
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Molecules 2015, 20(12), 22499-22519; https://doi.org/10.3390/molecules201219862
Submission received: 23 November 2015 / Revised: 7 December 2015 / Accepted: 8 December 2015 / Published: 15 December 2015
(This article belongs to the Collection Heterocyclic Compounds)

Abstract

:
An easy and efficient procedure for the synthesis of 4-indolylquinoline derivatives is described. This process involves two steps, the first of which is the Michael addition of indole to nitrochalcones promoted by sulfamic acid under solvent free conditions and the second step is a reductive cyclization of the indolylnitrochalcone intermediates to 4-indolylquinoline derivatives by Fe/HCl in ethanol. In both steps, the reactions are clean and the yields of products are high.

1. Introduction

Indole and quinoline are two important class of structural scaffolds that are found in a vast number of natural products and pharmaceutically active compounds [1,2,3,4,5,6]. Compounds containing both indole and quinoline rings are called as indolylquinolines and are known to exhibit a wide variety of biological activities, including antibiotic, antimicrobial and antifungal activities [7,8,9,10,11,12]. Although different kinds of indolylquinoline derivatives are known in the literature, three types of indolylquinoline derivatives such as 2-indolylquinoline, 3-indolylquinoline, and 4-indolylquinoline are frequently found in many bioactive compounds. For example, 2-indolylquinoline [13,14] exhibit antistaphylococcal activities, 3-indolylquinolines [15,16,17,18] inhibit the activity of PDGF-RTK, 4-indolylquinolines [19,20,21,22] have been known for potential treatments for allergic rhinitis, asthma and other inflammatory diseases (Figure 1) [13,14].
Figure 1. Bioactive indolylquinolines derivatives.
Figure 1. Bioactive indolylquinolines derivatives.
Molecules 20 19862 g001
A vast number of protocols are available for the synthesis of 2-indolylquinoline and 3-indolyl-quinoline derivatives [15,16,17,18], however, methods which describe the synthesis of 4-indolylquinoline derivatives are limited [19,20,21,22]. Marinelli and coworkers described a one-pot synthesis of 4-indolyl-quinoline derivatives from β-(2-aminophenyl)-α,β-ynones [23]. Recently, we reported a method for accessing 4-indolylquinoline derivatives through an inverse electron-demand aza-Diels-Alder reaction [24]. Some of these reported procedures required functionalized quinoline derivatives such as haloquinolines or indolylboronic acid derivatives and a few methods are associated with the use of expensive metal catalysts and starting materials. Hence, a simple and handy method for the synthesis of 4-indolylquinoline derivatives from easily available starting materials is desirable.
For the past decade, we have been working on the use of reductive cyclization reactions [25,26,27,28,29,30,31,32] to generate a wide variety of nitrogen heterocycles, including indolylquinoline derivatives, 3,3′-biindoles, quinoline derivatives, 2H-1,4-benzoxazin-3-(4H)-ones, carbazolone derivatives, 2,3-disubstituted indole derivatives, acridinones and phenathridine derivatives by using Fe/AcOH as a reagent [33,34,35,36]. In continuation to our interest on reductive cyclization reactions, we proposed to synthesize 4-indolylquinoline derivatives in two steps starting from 2-nitrochalcone derivatives and indoles. The proposed strategy for the synthesis of 4-indolyl quinoline derivatives is shown in the Scheme 1. This strategy involves two steps: a Michael addition of indole to 2-nitrochalcone followed by the reductive cyclization.
Scheme 1. The proposed strategy for the synthesis of 4-indolyl quinoline derivatives.
Scheme 1. The proposed strategy for the synthesis of 4-indolyl quinoline derivatives.
Molecules 20 19862 g002

2. Results and Discussion

To execute our strategy, we need to synthesize the Michael adducts of indoles and various 2-nitrochalcone derivatives. Although, several procedures describe the Michael addition reactions of indoles to chalcones [37,38,39,40,41,42], to our knowledge there is no procedure available for the Michael addition of 2-nitrochalcone with indole derivatives. On the other hand, we have reported Michael addition reactions of various 2-nitroalkenes and indoles using sulfamic acid as a catalyst under solvent free conditions to obtain the corresponding indolylnitroalkane derivatives in good to excellent yields [30]. We wished to adopt similar conditions to synthesize our starting materials, thus we tested the reaction of indole, 2-nitrochalcone, and sulfamic acid at the temperature of 90 °C under solvent free conditions. To our delight, the reaction was complete in 4 h and provided the corresponding 3-(1H-indol-3-yl)-3-(2-nitrophenyl)-1-phenylpropan-1-one derivative was obtained in good yield (Table 1, Entry 1).
Encouraged by this result, we applied these reaction conditions to synthesize various substituted indolylnitrochalcones. The reactions of indole with nitrochalcone derivatives with halogen group (F, Cl and Br) containing 2-nitrobenzalehydes and acetophenone proceeded quickly and afforded the desired products in good to excellent yields (Table 1, Entries 2–4). On the other hand, the reactions of indole with nitrochalcone derivatives derived from 2-nitrobenzaldehyde and ortho halogen group (Cl or Br) substituted acetophenones took place smoothly to provide the corresponding Michael adducts in quantitative yields.
Table 1. Michael addition of various 2-nitrochalcones and indole. Molecules 20 19862 i001
Table 1. Michael addition of various 2-nitrochalcones and indole. Molecules 20 19862 i001
Entry aNitrochalconeIndoleProductTime (h)Yield % b
1 Molecules 20 19862 i0022a Molecules 20 19862 i0034.083
2 Molecules 20 19862 i0042a Molecules 20 19862 i0050.576
3 Molecules 20 19862 i0062a Molecules 20 19862 i0071.089
4 Molecules 20 19862 i0082a Molecules 20 19862 i0092.599
5 Molecules 20 19862 i0102a Molecules 20 19862 i0112.599
6 Molecules 20 19862 i0122a Molecules 20 19862 i0132.599
7 Molecules 20 19862 i0142a Molecules 20 19862 i0152.099
8 Molecules 20 19862 i0162a Molecules 20 19862 i0172.599
9 Molecules 20 19862 i0182a Molecules 20 19862 i0192.593
10 Molecules 20 19862 i0202a Molecules 20 19862 i021398
11 Molecules 20 19862 i0222a Molecules 20 19862 i0231093
a All reactions were carried out by using 1.0 equiv. of 1 and 1.2 equiv. of 2a in the presence of 50 mol % of sulfamic acid; b Isolated yields.
Next, we investigated the reactions of unsubstituted nitrochalcone and various substituted indoles (Table 2).
Table 2. Michael addition of 2-nitrochalcone (1a) and various indoles. Molecules 20 19862 i024
Table 2. Michael addition of 2-nitrochalcone (1a) and various indoles. Molecules 20 19862 i024
Entry aNitrochalconeIndoleProductTime (h)Yield % b
1 Molecules 20 19862 i0252b Molecules 20 19862 i0262.081
2 Molecules 20 19862 i0272c Molecules 20 19862 i0281.585
3 Molecules 20 19862 i0292d Molecules 20 19862 i0303.089
4 Molecules 20 19862 i0312e Molecules 20 19862 i0321.099
5 Molecules 20 19862 i0332f Molecules 20 19862 i0341.090
6 Molecules 20 19862 i0352g Molecules 20 19862 i0361.097
7 Molecules 20 19862 i0372h Molecules 20 19862 i0382.070
8 Molecules 20 19862 i0392i Molecules 20 19862 i0407265
a All reactions were carried out by using 1.0 equiv. of 1 and 1.2 equiv. of 2a in the presence of 50 mol % of sulfamic acid; b Isolated yields.
When nitrochalcone was treated with electron-withdrawing group containing indoles such as 5-fluoroindole, 5-chloroindole and 5-bromoindole, the reactions produced the corresponding Michael adducts in good yields. On the other hand, the reactions of nitrochalcone and electron-donating indoles such as 5-methoxyindole and 6-methylindole provided its corresponding Michael adducts in excellent yields. Next, the reaction of N-methylindole and 2-nitrochalcone afford the desired Michael adduct in excellent yield. Further, the reaction of 2-nitrochalcone with 2-phenylindole or 2-methylindole afforded the corresponding Michael adducts in moderate yields. Moreover, the reactions of 2-nitrochalcone with 2-phenylindole or 2-methylindole took longer to go to completion (Table 2).
After the preparation of various substituted 3-(1H-indol-3-yl)-3-(2-nitrophenyl)-1-phenyl-propan-1-one derivatives, we then focused on the reductive cyclization of these compounds to 4-indolylquinoline derivatives. Initially, we treated 3-(1H-indol-3-yl)-3-(2-nitrophenyl)-1-phenyl-propan-1-one with the standard reductive cyclization agent Fe/AcOH [9] (Table 3, entry 1). Under these conditions the reaction afforded two compounds. From the 1H- and 13C-NMR spectral data and mass spectral analysis, it was revealed that the major product was the 4-indolylquinoline derivative and the minor product was the indole-eliminated 2-phenylquinoline derivative.
Then, we tried Zn as reducing reagent (Table 3, entries 2 and 3), but the results were not encouraging. As it is reported in the literature [43,44] that Fe/HCl is an efficient reductive cyclizing agent, next, we used Fe/HCl in EtOH (Table 3, entry 4) for this transformation. To our delight, the reaction produced the indolylquinoline derivative in excellent yield without any of the minor product. Further, when the reaction was performed using a mixed solvent such as ethanol and water (1:1), the reaction afforded an excellent yield of the 4-indolylquinoline derivative (Table 3, entry 5). However, the reaction time was longer in this case. Furthermore, when the reaction was performed in methanol it resulted in a decreased yield of the desired product (Table 3, entry 6). From the optimization results, the reaction condition using Fe/HCl in ethanol at reflux temperature (Table 3, entry 5) were found to be the best condition for the synthesis of 4-indolylquinoline derivatives from the corresponding 3-(1H-indol-3-yl)-3-(2-nitrophenyl)-1-phenylpropan-1-one derivatives (Table 3).
Table 3. Optimization studies for reductive cyclization of 3-(1H-indol-3-yl)-3-(2-nitrophenyl)-1-phenylpropan-1-one (3a). Molecules 20 19862 i041
Table 3. Optimization studies for reductive cyclization of 3-(1H-indol-3-yl)-3-(2-nitrophenyl)-1-phenylpropan-1-one (3a). Molecules 20 19862 i041
Entry aReductantSolventTime (h)Yield of 4a (%) bYield of 5a (%) b
1FeAcOH0.57224
2ZnAcOH101621
3Zn cTHF–H2O d2.000
4Fe eEtOH1.0900
5Fe eEtOH–H2O f4.0880
6Fe eMeOH10570
a 3a (1.0 equiv.), metal (6.0 equiv.), solvent (10 mL); b Isolated yields; c NH4Cl (1.1 equiv.); d THF–H2O (2:1); e HCl (1.0 equiv.); f EtOH–H2O (4:1).
Having the optimized reaction conditions in hand, we then investigated the scope and limitations of this protocol. As shown in Table 4, 3-(1H-indol-3-yl)-3-(2-nitrophenyl)-1-phenylpropan-1-one (3a) reacted under optimized reaction conditions to produce the 4-indolyl-quinoline derivatives in excellent yield.
Under the present reaction conditions, the substrates containing electron-withdrawing groups (F, Cl and Br) in the nitrochalcone part of 3-(1H-indol-3-yl)-3-(2-nitrophenyl)-1-phenylpropan-1-one reacted well and afforded the corresponding 4-indolyl-quinoline derivatives in good yields, while the reactions of the substrates possessing electron-donating groups provided the desired 4-indolylquinoline derivatives in excellent yields. Moreover, the substrate bearing a naphthalene ring also provided the corresponding product in 93% yield under the present reaction conditions. Next, the 3-(1H-indol-3-yl)-3-(2-nitrophenyl)-1-phenylpropan-1-one derivative containing a thiophene group was also reacted under the present reaction conditions to obtain the corresponding indolylquinoline derivative in excellent yield (Table 4).
Table 4. Reductive cyclization of substituted 3-(1H-indol-3-yl)-3-(2-nitrophenyl)-1-phenylpropan-1-one derivatives derived from various 2-nitrochalcone and indoles. Molecules 20 19862 i042
Table 4. Reductive cyclization of substituted 3-(1H-indol-3-yl)-3-(2-nitrophenyl)-1-phenylpropan-1-one derivatives derived from various 2-nitrochalcone and indoles. Molecules 20 19862 i042
Entry aIndolylnitrochalconeProductTime (h)Yield (%) b,c
1 Molecules 20 19862 i043 Molecules 20 19862 i0444.083
2 Molecules 20 19862 i045 Molecules 20 19862 i0460.576
3 Molecules 20 19862 i047 Molecules 20 19862 i0481.089
4 Molecules 20 19862 i049 Molecules 20 19862 i0502.599
5 Molecules 20 19862 i051 Molecules 20 19862 i0522.599
6 Molecules 20 19862 i053 Molecules 20 19862 i0542.599
7 Molecules 20 19862 i055 Molecules 20 19862 i0562.099
8 Molecules 20 19862 i057 Molecules 20 19862 i0582.599
9 Molecules 20 19862 i059 Molecules 20 19862 i0602.593
10 Molecules 20 19862 i061 Molecules 20 19862 i062393
11 Molecules 20 19862 i063 Molecules 20 19862 i0641093
a Condition: 3 (1.0 equiv.), Fe (6.0 equiv.), HCl (1.0 equiv.), EtOH (10 mL); b Isolated yields; c no trace of 5 was observed.
Next, we investigated the reactions of Michael adducts derived from nitrochalcone and various indoles. As shown in the Table 5, the 3-(1H-indol-3-yl)-3-(2-nitrophenyl)-1-phenylpropan-1-one derivatives derived from electron poor indoles (fluoro-, chloro-, and bromoindoles) underwent a smooth reductive cyclization to afford the desired 4-indolylquinoline derivatives in excellent yield, whereas, the substrates derived from the electron rich indoles produced the corresponding indolylquinoline derivatives in slightly lower yields than those of electron poor indoles. It is notable that the reactions of the substrate obtained from 2-phenyl or 2-methylindole provided the corresponding 4-indolylquinoline derivative in moderate yield along with a substantial amount of the indole cleaved product as byproduct. These results show that steric hindrance influences the elimination of indole to produce the indole-cleaved product (Table 5).
To further examine the influence of steric hindrance, we investigated the reactions of the 3-(1H-indol-3-yl)-3-(2-nitrophenyl)-1-phenylpropan-1-one substrates containing a methyl group adjacent to the nitro group as well the substrates derived from 2,5-dimethylindoles. As shown in the Table 6, steric hindrance adjacent to the nitro group has less influence on the reaction outcome, as the substrate 3t gave the corresponding indolylquinoline in good yield along with traces of the indole cleaved product. However, when the substrate 3u derived from 2,5-dimethylindole was treated under the present reaction conditions, we obtained 66% of indolylquinoline derivative and 30% of indole-cleaved product. Furthermore, we obtained only indole-cleaved product, when the substrate 3v containing a methyl group adjacent to the nitro as well as the second indole position was used. It is important to note that the reactions took longer when the methyl group was adjacent to the nitro group as in case of entries 2, 3 in Table 6.
Table 5. Reductive cyclization of 3-(1H-indol-3-yl)-3-(2-nitrophenyl)-1-phenylpropan-1-one derivatives derived from various indoles and 2-nitrochalcone. Molecules 20 19862 i065
Table 5. Reductive cyclization of 3-(1H-indol-3-yl)-3-(2-nitrophenyl)-1-phenylpropan-1-one derivatives derived from various indoles and 2-nitrochalcone. Molecules 20 19862 i065
Entry aIndolylnitrochalconeProductTime (h)Yield % b
1 Molecules 20 19862 i066 Molecules 20 19862 i0671.599
2 Molecules 20 19862 i068 Molecules 20 19862 i0691.599
3 Molecules 20 19862 i070 Molecules 20 19862 i0711.599
4 Molecules 20 19862 i072 Molecules 20 19862 i0731.082
5 Molecules 20 19862 i074 Molecules 20 19862 i0751.085
6 Molecules 20 19862 i076 Molecules 20 19862 i0771.083
7 Molecules 20 19862 i078 Molecules 20 19862 i0793.066 c
8 Molecules 20 19862 i080 Molecules 20 19862 i0816.057 d
a Condition: 3 (1.0 equiv.), Fe (6.0 equiv.), HCl (1.0 equiv.), EtOH (10 mL); b Isolated yields; c 17% of product 5 formed along with 4r (66%); d 30% of 5 formed along with 4s (57%)
Table 6. Reductive cyclization of sterically hindered 3-(1H-indol-3-yl)-3-(2-nitrophenyl)-1-phenylpropan-1-one derivatives. Molecules 20 19862 i082
Table 6. Reductive cyclization of sterically hindered 3-(1H-indol-3-yl)-3-(2-nitrophenyl)-1-phenylpropan-1-one derivatives. Molecules 20 19862 i082
Entry aSubstrateSolventTime (h)Yield of 4 (%) bYield of 5 (%) b
1 Molecules 20 19862 i083 Molecules 20 19862 i08424858
2 Molecules 20 19862 i085 Molecules 20 19862 i0861.06630
3 Molecules 20 19862 i087 Molecules 20 19862 i08824070
a Condition: 3 (1.0 equiv.), Fe (6.0 equiv.), HCl (1.0 equiv.), EtOH (10 mL); b Isolated yields.
A reaction mechanism for the formation of the indolylquinoline as well as the indole-cleaved product from 3-(1H-indol-3-yl)-3-(2-nitrophenyl)-1-phenylpropan-1-one (3a) is proposed based on our previous work (Scheme 2). Initially, the nitro group of the 3-(1H-indol-3-yl)-3-(2-nitrophenyl)-1-phenylpropan-1-one (3a) is reduced to an amino group by Fe/HCl, then it attacks the carbonyl group in the presence of FeCl3 in the solvent, forming a dihydroquinoline intermediate. The dihydroquinoline intermediate compound is unstable, and undergoes aromatization by the loss of hydrogen or the indole moiety to give either 4a or 5a. Besides, we also anticipate that indolylquinoline derivative 4a may also undergo a slow decomposition to indole-cleaved product 5a through reductive elimination. To explore this reductive elimination possibility, the indolylquinoline 4a was treated with Fe/AcOH under the identical conditions used in the preparation of indolylquinoline derivatives. We obtained around 14% of indole-cleaved product along with 82% of the unchanged indolylquinoline 4a after 24 h. The result was similar even when reaction was conducted with Fe/HCl used as reagent in ethanol. However, when the reaction was performed with FeCl3, the indolylquinoline was unchanged. From these experiments, we cannot exclude this route for the formation of the indole-cleaved product.
Scheme 2. Mechanistic route for the reductive cyclization of 3-(1H-indol-3-yl)-3-(2-nitrophenyl)-1-phenylpropan-1-one derivatives.
Scheme 2. Mechanistic route for the reductive cyclization of 3-(1H-indol-3-yl)-3-(2-nitrophenyl)-1-phenylpropan-1-one derivatives.
Molecules 20 19862 g003

3. Experimental Section

3.1. General Information

All chemicals were purchased from various commercial sources and used directly without further purification. Analytical thin-layer chromatography was performed using E. Merck (New York, NY, USA) silica gel 60F glass plates and E. Merck silica gel 60 (230–400 mesh) was used in flash chromatography separations. MS were measured by a JMS-HX110 spectrometer (JEOL, Hsinchu, Japan). HRMS spectra were recorded using ESI-TOF or EI+ mode or FAB+. 1H- (400 MHz) and 13C-NMR (100 MHz) spectra were recorded with an Advance EX 400 MHz spectrometer (Bruker, San Francisco, CA, USA). Chemical shifts are reported in parts per million (δ) using TMS as an internal standard and coupling constant were expressed in hertz. IR spectra were performed on a 100 series FT-IR instrument (Perkin Elmer, Waltham, MA, USA). Melting points were recorded using a capillary melting point apparatus (Electrothermal, Staffordshire, UK) and are uncorrected. All substrates were prepared using literature procedures.

3.2. General Procedure for the Reaction of Indoles with Nitrochalcones to give Products 3a3v

The mixture of nitrochalcone (2.0 mmol), indole (2.2 mmol), and sulfamic acid (1 mmol, 0.5 eq.) was heated at 90 °C until the complete consumption of starting materials, which was monitored by TLC. Then, the reaction mixture was allowed to cool to room temperature, diluted with ethyl acetate (20 mL) and washed with water, followed by brine. The organic layer was separated, dried over anhydrous MgSO4, and concentrated in vacuum to obtain the crude product. The residue was purified by flash column chromatography (petroleum ether/ethyl acetate) to obtain the desired products 3a3v. (The 1H-, 13C-NMR spectra of the compounds (3a3v) was showed in supplementary).
3-(1H-Indol-3-yl)-3-(2-nitrophenyl)-1-phenylpropan-1-one (3a): Pale crystalline yellow solid (crystallized from ethyl acetate and hexane) with a melting point of 176–178 °C; IR (KBr): 3320, 3050, 1684, 1525, 1354, 741 cm−1. 1H-NMR (DMSO-d6) δ 10.99 (s, 1H), 8.00 (d, J = 7.5 Hz, 2H), 7.83 (d, J = 8.0 Hz, 1H), 7.61 (d, J = 6.3 Hz, 2H), 7.54–7.48 (m, 3H), 7.42–7.36 (m, 2H), 7.38–7.33 (m, 2H), 7.04 (t, J = 7.3 Hz, 1H), 6.90 (t, J = 4.7 Hz, 1H), 5.45 (t, J = 6.8 Hz, 1H), 4.04 (dd, J = 18.0, 6.4 Hz, 1H), 3.88 (dd, J = 18.0, 7.6 Hz, 1H); 13C-NMR (DMSO-d6) δ 197.8, 149.7, 138.0, 136.4, 136.4, 133.3, 132.6, 130.1, 128.6, 128.0, 127.2, 126.2, 123.7, 123.1, 121.2, 118.6, 118.4, 116.2, 111.5, 44.5, 31.5; MS (EI) m/z (relative intensity) 370 (M+, 36), 353 (47), 251 (100), 231 (59), 204 (65), 105 (87); HRMS (EI) m/z calcd for C23H18N2O3 (M+) 370.1317, found 370.1310.
3-(5-Fluoro-2-nitrophenyl)-3-(1H-indol-3-yl)-1-phenylpropan-1-one (3b): Purified by column chromatography using 1:5 ethyl acetate and hexane. After concentration in vacuo it give a brown oil; IR (KBr): 3340, 3056, 1670, 1601, 1520, 1474, 1347, 1287, 974, 623 cm−1. 1H-NMR (CDCl3) δ 8.16 (s, 1H), 7.97–7.95 (m, 2H), 7.90 (dd, J = 9.0, 5.2 Hz, 1H), 7.56 (t, J = 7.4 Hz, 1H), 7.47–7.43 (m, 3H), 7.32 (d, J = 8.2 Hz, 1H), 7.16 (dt, J = 7.6, 0.7 Hz, 1H), 7.12–7.09 (m, 2H), 7.03 (dt, J = 7.1, 0.4 Hz, 1H), 6.95 (ddd, J = 9.2, 6.5, 2.7 Hz, 1H), 5.79 (t, J = 7.1 Hz, 1H), 3.86 (dd, J = 17.3, 7.4 Hz, 1H), 3.76 (dd, J = 17.3, 7.4 Hz, 1H); 13C-NMR (CDCl3) δ 197.4, 164.7 (d, JC–F = 254 Hz), 146.1 (d, JC–F = 3 Hz), 143.2, 143.1, 136.7 (d, JC–F = 10 Hz), 133.6, 128.9, 128.3, 127.5 (d, JC–F = 10 Hz), 126.5, 122.8, 122.2, 120.1, 119.4, 117.0 (d, JC–F = 24 Hz), 116.9, 114.6 (d, JC–F = 23 Hz), 111.5, 44.9, 33.2; HRMS (EI) m/z calcd for C23H18N2O3F ([M + H]+) 389.1301, found 389.1318.
3-(5-Chloro-2-nitrophenyl)-3-(1H-indol-3-yl)-1-phenylpropan-1-one (3c): Purified by column chromatography using 1:4 ethyl acetate and hexane. After concentration in vacuo a pale brown solid with a melting point of 151–153 °C was obtained; 1H-NMR (CDCl3) δ 8.09 (s, 1H), 7.95 (d, J = 8.0 Hz, 2H), 7.78 (d, J = 8.7, 1H), 7.55 (t, J = 7.4 Hz, 1H), 7.46–7.42 (m, 3H), 7.38 (d, J = 2.0, 1H), 7.33 (d, J = 8.1, 1H), 7.25 (s, 1H), 7.16 (t, J = 7.4, 1H), 7.12 (s, 1H), 7.03 (t, J = 7.6, 1H), 5.73 (t, J = 7.2, 1H), 3.87 (dd, J = 17.4, 6.8 Hz, 1H), 3.75 (dd, J = 17.2, 7.7 Hz, 1H); 13C-NMR (CDCl3) δ 197.3, 148.4, 141.4, 139.1, 136.8, 136.7, 133.6, 130.2, 128.9, 128.3, 127.6, 126.5, 126.1, 122.8, 122.2, 120.1, 119.4, 116.8, 111.5, 44.9, 32.9; MS (EI) m/z (relative intensity) 406 ([M + 2]+, 8), 404 (M+ , 25), 387 (29), 285 (85), 265 (41), 253 (33), 204 (26), 203 (11), 132 (11), 105 (100); HRMS (EI) m/z calcd. for C23H17N2O3Cl (M+) 404.0928, found 404.0926.
3-(5-Bromo-2-nitrophenyl)-3-(1H-indol-3-yl)-1-phenylpropan-1-one (3d): Purified by column chromatography using 1:4 ethyl acetate and hexane. Concentration in vacuo give a pale brown solid with a melting point of 166–168 °C; 1H-NMR (CDCl3) δ 8.14 (s, 1H), 7.93 (d, J = 7.4 Hz, 2H), 7.66 (d, J = 8.6, 1H), 7.55–7.52 (m, 2H), 7.46–7.40 (m, 3H), 7.37 (dd, J = 8.6, 2.0 Hz, 1H), 7.29 (d, J = 8.2 Hz, 1H), 7.14 (t, J = 7.3 Hz, 1H), 7.07 (d, J = 1.9 Hz, 1H), 7.01 (t, J = 7.5 Hz, 1H), 5.70 (t, J = 7.1 Hz, 1H), 3.85 (dd, J = 17.3, 6.8 Hz, 1H), 3.72 (dd, J = 17.2, 7.6 Hz, 1H); 13C-NMR (CDCl3) δ 197.3, 149.0, 141.4, 136.8, 136.7, 133.6, 133.2, 130.6, 128.9, 128.3, 127.5, 126.5, 126.1, 122.8, 122.2, 120.1, 119.4, 116.8, 111.5, 44.9, 32.8; MS (EI) m/z (relative intensity) 450 ([M + 2]+, 23), 448 (M+, 23), 431 (26), 329 (100), 311 (63), 285 (30), 217 (30), 206 (54), 176 (16), 132 (27), 105 (95); HRMS (EI) m/z calcd. for C23H17N2O3Br (M+) 448.0423, found 448.0432.
1-(2-Chlorophenyl)-3-(1H-indol-3-yl)-3-(2-nitrophenyl)propan-1-one (3e): Yellow crystalline solid (crystallized from ethyl acetate and hexane) with a melting point of 114–116 °C; 1H-NMR (CDCl3) δ 8.07 (s, 1H), 7.80 (d, J = 8.1 Hz, 1H), 7.43–7.21 (m, 9H), 7.14 (m, 2H), 6.98 (t, J = 7.5 Hz, 1H), 5.55 (t, J = 7.4 Hz, 1H), 3.84 (dd, J = 17.0, 7.0 Hz, 1H), 3.77 (dd, J = 17.0, 8.1 Hz, 1H); 13C-NMR (CDCl3) δ 201.3, 149.8, 138.9, 138.4, 136.7, 132.8, 131.9, 130.8, 130.6, 130.2, 129.0, 127.4, 127.1, 126.5, 124.5, 122.6, 122.5, 119.8, 119.3, 116.7, 111.4, 49.3, 33.3; MS (EI) m/z (relative intensity) 406 ([M + 2]+, 6), 404 (M+ , 18), 354 (24), 269 (44), 251 (74), 207 (46), 204 (42), 139 (100), 105 (76); HRMS (EI) m/z calcd for C23H17N2O3Cl (M+) 404.0928, found 404.0929.
1-(2-Bromophenyl)-3-(1H-indol-3-yl)-3-(2-nitrophenyl)propan-1-one (3f): Purified by column chromatography using 1:5 ethyl acetate and hexane. After concentration in vacuo a yellow crystalline solid (from ethyl acetate and hexane) with a melting point of 132–134 °C was obtained; 1H-NMR (CDCl3) δ 8.08 (s, 1H), 7.81 (d, J = 8.1 Hz, 1H), 7.54 (d, J = 7.6 Hz, 1H), 7.44–7.38 (m, 2H), 7.33–7.30 (m, 3H), 7.26–7.19 (m, 3H), 7.15–7.12 (m, 2H), 6.98 (t, J = 7.7 Hz, 1H), 5.54 (t, J = 7.4 Hz, 1H), 3.83 (dd, J = 16.9, 6.8 Hz, 1H), 3.74 (dd, J = 16.9, 8.0 Hz, 1H); 13C-NMR (CDCl3) δ 202.0, 149.9, 141.1, 138.3, 136.7, 133.8, 132.9, 131.8, 130.3, 128.7, 127.6, 127.5, 126.5, 124.5, 122.7, 122.5, 119.8, 119.3, 118.7, 116.6, 111.4, 49.0, 33.4; MS (EI) m/z (relative intensity) 450 ([M + 2]+, 10), 448 (M+, 10), 354 (27), 251 (60), 204 (50), 183 (100), 155 (16), 132 (14), 105 (13); HRMS (EI) m/z calcd. for C23H17N2O3Br (M+) 448.0423, found 448.0420.
3-(1H-Indol-3-yl)-3-(2-nitrophenyl)-1-p-tolylpropan-1-one (3g): Purified by column chromatography using 1:5 ethyl acetate and hexane. After concentration in vacuo an orange oil was obtained; 1H-NMR (CDCl3) δ 8.01 (s, 1H), 7.86 (d, J = 7.9 Hz, 2H), 7.79 (d, J = 8.0 Hz, 1H), 7.46–7.38 (m, 3H), 7.31 (t, J = 8.2 Hz, 2H), 7.24 (d, J = 8.0 Hz, 2H), 7.15 (t, J = 7.3 Hz, 1H), 7.11 (s, 1H), 7.00 (t, J = 7.6 Hz, 1H), 5.68 (t, J = 7.2 Hz, 1H), 3.84 (dd, J = 16.8, 7.4 Hz, 1H), 3.77 (dd, J = 17.2, 7.8 Hz, 1H), 2.39 (s, 3H); 13C-NMR (CDCl3) δ 197.4, 150.1, 144.3, 139.0, 136.8, 134.4, 132.7, 130.1, 129.5, 128.4, 127.3, 126.6, 124.4, 122.5, 122.3, 119.8, 119.4, 117.4, 111.4, 44.9, 33.2, 21.8; MS (EI) m/z (relative intensity) 384 (M+, 46), 350 (39), 251 (100), 232 (40), 206 (38), 119 (63); HRMS (EI) m/z calcd for C24H20N2O3 (M+) 384.1474, found 384.1473.
3-(1H-Indol-3-yl)-1-(4-methoxyphenyl)-3-(2-nitrophenyl)propan-1-one (3h): Purified by column chromatography using 1:5 ethyl acetate and hexane. After concentration in vacuo a yellow solid with a melting point of 207–209 °C was obtained; 1H-NMR (400 MHz,DMSO-d6) δ 10.96 (s, 1H), 7.98 (d, J = 8.8 Hz, 2H), 7.81 (d, J = 8.0 Hz, 1H), 7.59 (d, J = 7.2 Hz, 1H), 7.52 (t, J = 7.3 Hz, 1H), 7.39–7.31 (m, 4H), 7.05–7.00 (m, 3H), 6.89 (t, J = 7.4 Hz, 1H), 5.41 (t, J = 7.2 Hz, 1H), 3.95 (dd, J = 17.7, 6.6 Hz, 1H), 3.83 (s, 3H), 3.77 (dd, J = 17.7, 8.0 Hz, 1H); 13C-NMR (DMSO-d6) δ 196.1, 163.2, 149.7, 138.8, 136.3, 132.6, 130.4, 130.0, 129.5, 127.1, 126.2, 123.7, 123.0, 121.2, 118.5, 118.4, 116.3, 113.8, 111.4, 55.5, 44.0, 31.6; MS (EI) m/z (relative intensity) 400 (M+, 25), 366 (29), 250 (63), 222 (29), 206 (22), 135 (100); HRMS (EI) m/z calcd for C24H20N2O4 (M+) 400.1423, found 400.1428.
1-(Benzo[d][1,3]dioxol-5-yl)-3-(1H-indol-3-yl)-3-(2-nitrophenyl)propan-1-one (3i): Purified by column chromatography using 1:5 ethyl acetate and hexane. After concentration in vacuo a pale yellow solid with a melting point of 150–152 °C was obtained; 1H-NMR (CDCl3) δ 8.05 (s, 1H), 7.78 (dd, J = 8.0, 0.8 Hz, 1H), 7.58 (dd, J = 8.2, 1.7 Hz, 1H), 7.44–7.37 (m, 4H), 7.30–7.26 (m, 2H), 7.13 (dt, J = 7.2, 0.5 Hz, 1H), 7.08 (d, J = 2.0 Hz, 1H), 6.99 (dt, J = 7.5, 0.5 Hz, 1H), 6.81 (d, J = 8.1 Hz, 1H), 6.01 (s, 2H), 5.65 (t, J = 7.2 Hz, 1H), 3.77 (dd, J = 16.8, 7.2 Hz, 1H), 3.70 (dd, J = 17.0, 7.5 Hz, 1H); 13C-NMR (CDCl3) δ 195.8, 152.1, 150.2, 148.4, 138.9, 136.8, 132.7, 131.8, 130.2, 127.3, 126.6, 124.6, 124.5, 122.5, 122.3, 119.9, 119.5, 117.4, 111.4, 108.2, 108.1, 102.0, 44.8, 33.4; MS (EI) m/z (relative intensity) 414 (M+, 18), 380 (17), 251 (65), 207 (20), 148 (100); HRMS (EI) m/z calcd for C24H18N2O5 (M+) 414.1216, found 414.1209.
3-(1H-Indol-3-yl)-1-(naphthalen-2-yl)-3-(2-nitrophenyl)propan-1-one (3j): Purified by column chromatography using 1:5 ethyl acetate and hexane. After concentration in vacuo a yellow solid with a melting point of 185–187 °C was isolated; 1H-NMR (DMSO-d6) δ 10.98 (s, 1H), 8.79 (s, 1H), 8.12 (d, J = 7.8 Hz, 1H), 7.99–7.96 (m, 3H), 7.84 (dd, J = 8.1, 1.1 Hz, 1H), 7.67–7.62 (m, 3H), 7.54 (dt, J = 7.7, 1.1 Hz, 1H), 7.44 (d, J = 2.2 Hz, 1H), 7.42–7.38 (m, 2H), 7.33 (d, J = 8.1 Hz, 1H), 7.04 (dt, J = 7.1, 0.8 Hz, 1H), 6.90 (dt, J = 7.4, 0.6 Hz, 1H), 5.49 (t, J = 7.2 Hz, 1H), 4.19 (dd, J = 17.9, 6.8 Hz, 1H), 3.99 (dd, J = 17.8, 7.7 Hz, 1H); 13C-NMR (DMSO-d6) δ 197.7, 149.7, 138.8, 136.4, 135.1, 133.7, 132.7, 132.2, 130.1, 130.1, 129.6, 128.7, 128.2, 127.6, 127.2, 126.9, 126.2, 123.8, 123.5, 123.1, 121.2, 118.6, 118.4, 116.2, 111.5, 44.5, 31.7; MS (EI) m/z (relative intensity) 420 (M+, 5), 251 (19), 155 (100), 127 (36); HRMS (EI) m/z calcd for C27H20N2O3 (M+) 420.1474, found 420.1465.
3-(1H-Indol-3-yl)-3-(2-nitrophenyl)-1-(thiophen-2-yl)propan-1-one (3k): Purified by column chromatography using 1:5 ethyl acetate and hexane. After concentration in vacuo a pale brown solid with a melting point of 146–148 °C was obtained; 1H-NMR (CDCl3) δ 8.04 (s, 1H), 7.81–7.79 (m, 2H), 7.61 (d, J =4.7 Hz, 1H), 7.47–7.40 (m, 2H), 7.36–7.28 (m, 3H), 7.17–7.10 (m, 3H), 7.00 (t, J = 7.5 Hz, 1H), 5.67 (t, J = 7.4 Hz, 1H), 3.79 (dd, J = 14.5, 5.8 Hz, 1H), 3.74 (dd, J = 14.6, 5.6 Hz, 1H); 13C-NMR (CDCl3) δ 190.7, 150.0, 144.1, 138.6, 136.7, 134.1, 132.8, 132.3, 130.3, 128.4, 127.5, 126.6, 124.5, 122.5, 119.8, 119.3, 116.9, 111.5, 45.6, 33.6; MS (EI) m/z (relative intensity) 251 (22), 204 (25), 111 (100); HRMS (EI) m/z calcd for C21H26N2O3S (M+) 376.0882, found 376.0880.
3-(5-Fluoro-1H-indol-3-yl)-3-(2-nitrophenyl)-1-phenylpropan-1-one (3l): Purified by column chromatography using 1:4 ethyl acetate and hexane. After concentration in vacuo a yellow solid with a melting point of 192–194 °C was obtained; 1H-NMR (DMSO-d6) δ 11.10 (s, 1H), 7.99 (d, J = 7.7 Hz, 2H), 7.83 (d, J = 8.1 Hz, 1H), 7.63–7.61 (m, 2H), 7.56–7.48 (m, 4H), 7.38 (t, J = 7.8 Hz, 1H), 7.33 (dd, J = 8.8, 4.6 Hz, 1H), 7.15 (dd, J = 10.2, 2.0 Hz, 1H), 6.88 (dt, J = 9.2, 2.2 Hz, 1H), 5.37 (t, J = 7.3 Hz, 1H), 4.00 (dd, J = 18.1, 6.2 Hz, 1H), 3.92 (dd, J = 18.1, 8.1 Hz, 1H); 13C-NMR (DMSO-d6) δ 197.8, 156.7 (d, JC–F = 230 Hz), 149.8, 138.5, 136.4, 133.3, 133.1, 132.7, 129.9, 128.6, 128.0, 127.2, 126.4 (d, JC–F = 10 Hz), 125.3, 123.8, 116.6 (d, JC–F = 5 Hz), 112.5 (d, JC–F = 10 Hz), 109.4 (d, JC–F = 26 Hz), 103.2 (d, JC–F = 23 Hz); MS (EI) m/z (relative intensity) 388 (M+, 29), 371 (25), 269 (92), 222 (56); HRMS (EI) m/z calcd for C23H17N2O3F (M+) 388.1223, found 388.1227.
3-(5-Chloro-1H-indol-3-yl)-3-(2-nitrophenyl)-1-phenylpropan-1-one (3m): Purified by column chromatography using 1:4 ethyl acetate and hexane. After concentration in vacuo a pale yellow solid with a melting point of 198–200 °C was obtained; 1H-NMR (DMSO-d6) δ 11.22 (s, 1H), 7.99 (d, J = 7.4 Hz, 2H), 7.84 (d, J = 8.0 Hz, 1H), 7.64–7.61 (m, 2H), 7.56–7.48 (m, 4H), 7.46 (d, J = 1.5 Hz, 1H), 7.40–7.34 (m, 2H), 7.04 (dd, J = 8.6, 1.8 Hz, 1H), 5.38 (t, J = 7.2 Hz, 1H), 4.00 (dd, J = 18.2, 6.4 Hz, 1H), 3.92 (dd, J = 18.2, 8.4 Hz, 1H); 13C-NMR (DMSO-d6) δ 197.7, 149.8, 138.5, 136.4, 134.8, 133.3, 132.8, 130.0, 128.6, 127.3, 127.3, 125.1, 123.9, 123.3, 121.2, 117.7, 116.2, 113.1, 44.5, 31.3; MS (EI) m/z (relative intensity) 406 ([M + 2]+, 10), 404 (M+, 31), 387 (25), 285 (92), 265 (30), 253 (29), 205 (32), 204 (19), 105 (94), 84 (100); HRMS (EI) m/z calcd for C23H17N2O3Cl (M+) 404.0928, found 404.0930.
3-(5-Bromo-1H-indol-3-yl)-3-(2-nitrophenyl)-1-phenylpropan-1-one (3n): Purified by column chromatography using 1:5 ethyl acetate and hexane. Concentration in vacuo gave a brown solid with a melting point of 152–154 °C; 1H-NMR (DMSO-d6) δ 11.25 (s, 1H), 8.00 (d, J = 7.9 Hz, 2H), 7.84 (d, J = 8.1 Hz, 1H), 7.63–7.60 (m, 3H), 7.56–7.52 (m, 2H), 7.50 (t, J = 7.6 Hz, 2H), 7.38 (t, J = 8.0 Hz, 1H), 7.32 (d, J = 8.6 Hz, 1H), 7.16 (d, J = 8.6 Hz, 1H), 5.40 (t, J = 7.2, 1H), 4.01 (dd, J = 18.2, 6.0 Hz, 1H), 3.92 (dd, J = 18.2, 8.4 Hz, 1H); 13C-NMR (DMSO-d6) δ 197.7, 149.7, 138.4, 136.4, 135.0, 133.3, 132.8, 129.9, 128.6, 128.0, 128.0, 127.3, 124.9, 123.8, 123.7, 120.7, 116.1, 113.5, 111.2, 44.5, 31.2; MS (EI) m/z (relative intensity) 450 ([M + 2]+, 7), 448 (M+, 7), 431 (7), 329 (26), 311 (23), 284 (16), 217 (13), 205 (23), 105 (100); HRMS (EI) m/z calcd for C23H17N2O3Br (M+) 448.0423, found 448.0414.
3-(5-Methoxy-1H-indol-3-yl)-3-(2-nitrophenyl)-1-phenylpropan-1-one (3o): Purified by column chromatography using 1:5 ethyl acetate and hexane. After concentration in vacuo a green oil was obtained; 1H-NMR (CDCl3) δ 8.17 (s, 1H), 7.92 (s, 1H), 7.89 (d, J = 1.3 Hz, 1H), 7.71 (dd, J = 8.0, 1.1 Hz, 1H), 7.49 (t, J = 7.5 Hz, 1H), 7.37 (m, 3H), 7.31 (dt, J = 7.7, 1.0 Hz, 1H), 7.19 (dt, J = 7.5, 1.2 Hz, 1H), 7.08 (d, J = 8.8 Hz, 1H), 6.98 (d, J = 2.1 Hz, 1H), 6.88 (d, J = 2.4 Hz, 1H), 6.73 (dd, J = 8.8, 2.4 Hz, 1H), 5.61 (t, J = 7.2 Hz, 1H), 3.79 (dd, J = 17.2, 6.9 Hz, 1H), 3.72 (dd, J = 17.2, 7.5 Hz, 1H), 3.66 (s, 3H); 13C-NMR (CDCl3) δ 197.7, 154.3, 150.4, 138.8, 136.8, 133.5, 132.7, 131.8, 130.2, 128.9, 128.3, 127.4, 127.1, 124.4, 122.7, 117.4, 112.9, 112.1, 101.2, 55.9, 45.0, 33.0, MS (EI) m/z (relative intensity) 400 (M+ , 32), 383 (25), 281 (68), 261 (39), 249 (24), 204 (16), 162 (12), 105 (100); HRMS (EI) m/z calcd for C24H20N2O4 (M+) 400.1423, found 400.1431.
3-(7-Methyl-1H-indol-3-yl)-3-(2-nitrophenyl)-1-phenylpropan-1-one (3p): Purified by column chromatography using 1:5 ethyl acetate and hexane. After concentration in vacuo a pale green solid with a melting point of 139–141 °C was obtained; 1H-NMR (CDCl3) δ 7.97–7.95 (m, 3H), 7.80 (d, J = 8.1 Hz, 1H), 7.55 (t, J = 7.36 Hz, 1H), 7.46–7.39 (m, 4H), 7.31–7.23 (m, 2H), 7.11 (d, J = 1.8 Hz, 1H), 6.96–6.91 (m, 2H), 5.67 (t, J = 7.2 Hz, 1H), 3.87 (dd, J = 16.7, 7.2 Hz, 1H), 3.80 (dd, J = 16.7, 6.6 Hz, 1H), 2.45 (s, 3H); 13C-NMR (CDCl3) δ 197.8, 150.1, 138.9, 136.8, 136.3, 133.4, 132.8, 130.1, 128.8, 128.3, 127.3, 126.1, 124.5, 123.1, 122.0, 120.6, 120.1, 117.8, 117.2, 45.0, 33.3, 16.7; MS (EI) m/z (relative intensity) 384 (M+, 23), 367 (28), 265 (60), 245 (41), 219 (32), 204 (12), 146 (10), 105 (100); HRMS (EI) m/z calcd for C24H20N2O3 (M+) 384.1474, found 384.1476.
3-(1-Methyl-1H-indol-3-yl)-3-(2-nitrophenyl)-1-phenylpropan-1-one (3q): Purified by column chromatography using 1:5 ethyl acetate and hexane. After concentration in vacuo a yellow solid with a melting point of 166–168 °C was obtained; 1H-NMR (CDCl3) δ 7.96 (d, J = 7.7 Hz, 2H), 7.80 (d, J = 8.1 Hz, 1H), 7.55 (t, J = 7.2 Hz, 1H), 7.47–7.39 (m, 5H), 7.30–7.24 (m, 2H), 7.18 (t, J = 7.2 Hz, 1H), 7.00 (t, J = 7.3 Hz, 1H), 6.95 (s, 1H), 5.67 (t, J = 7.2 Hz, 1H), 3.86 (dd, J = 16.9, 7.2 Hz, 1H), 3.80 (dd, J = 16.8, 6.8 Hz, 1H), 3.74 (s, 3H); 13C-NMR (CDCl3) δ 197.6, 150.1, 139.1, 137.5, 136.9, 133.4, 132.7, 130.1, 128.8, 128.3, 127.3, 127.0, 127.0, 124.5, 122.2, 119.6, 119.4, 115.9, 109.5, 45.2, 33.1, 33.0; MS (EI) m/z (relative intensity) 384 (M+, 24), 367 (55), 265 (100), 248 (45), 218 (58), 217 (23), 146 (20), 105 (58); HRMS (EI) m/z calcd for C24H20N2O3 (M+) 384.1474, found 384.1478.
3-(2-Methyl-1H-indol-3-yl)-3-(2-nitrophenyl)-1-phenylpropan-1-one (3r): Purified by column chromatography using 1:5 ethyl acetate and hexane. Concentration in vacuo gave a yellow solid with a melting point of 129–131 °C; 1H-NMR (CDCl3) δ 7.88 (s, 1H), 7.86 (d, J = 1.0 Hz, 1H), 7.77 (s, 1H), 7.72 (d, J = 7.9 Hz, 1H), 7.68 (d, J = 8.0 Hz, 1H), 7.53–7.47 (m, 2H), 7.38 (t, J = 7.8 Hz, 2H), 7.31 (t, J = 8.0 Hz, 2H), 7.20 (d, J = 80 Hz, 1H), 7.04 (t, J = 7.2 Hz, 1H), 6.95 (t, J = 7.3 Hz, 1H), 5.71 (t, J = 7.2 Hz, 1H), 3.95 (dd, J = 16.9, 7.8 Hz, 1H), 3.84 (dd, J = 16.9, 6.7 Hz, 1H); 13C-NMR (CDCl3) δ 198.0, 150.4, 138.6, 137.0, 135.7, 133.3, 133.1, 132.3, 129.3, 128.8, 128.2, 127.6, 127.3, 124.9, 121.1, 119.7, 118.6, 111.5, 110.8, 43.3, 33.1, 12.2; MS (EI) m/z (relative intensity) 384 (M+, 53), 367 (17), 265(100), 247 (92), 218 (60), 217 (46), 146 (67), 105 (55); HRMS (EI) m/z calcd for C24H20N2O3 (M+) 384.1474, found 384.1481.
3-(2-Nitrophenyl)-1-phenyl-3-(2-phenyl-1H-indol-3-yl)propan-1-one (3s): Purified by column chromatography using 1:5 ethyl acetate and hexane. After concentration in vacuo a deep brown oil was obtained; IR (KBr): 3390, 3059, 1682, 1601, 1526, 1451, 1351, 741, 698 cm−1. 1H-NMR (CDCl3) δ 8.15 (s,1H), 7.74 (d, J = 7.4 Hz, 2H), 7.67 (t, J = 7.1 Hz, 2H), 7.60 (d, J = 7.9 Hz, 1H), 7.43 (t, J = 7.4 Hz, 1H), 7.36–7.20 (m, 10H), 7.11 (t, J = 7.2 Hz, 1H), 7.04 (t, J = 7.5 Hz, 1H), 5.80 (t, J = 7.3 Hz, 1H), 4.05 (dd, J = 17.4, 8.5 Hz, 1H), 3.78 (dd, J = 17.3, 6.1 Hz, 1H); 13C-NMR (CDCl3) δ 197.6, 149.2, 139.0, 136.6, 136.5, 136.0, 132.9, 132.5, 132.5, 130.1, 128.6, 128.5, 128.4, 128.1, 127.9, 127.8, 127.2, 124.5, 121.9, 119.9, 119.8, 111.8, 111.7, 44.1, 33.8; HRMS (ESI) m/z calcd for C29H22N2O3Na ([M + Na]+) 469.1528, found 469.1519.
3-(1H-Indol-3-yl)-3-(3-methyl-2-nitrophenyl)-1-phenylpropan-1-one (3t): Purified by column chromatography using 1:5 ethyl acetate and hexane. After concentration in vacuo a pale pink solid with a melting point of 191–193 °C was obtained; 1H-NMR (CDCl3) δ 8.00 (s, 1H), 7.93 (d, J = 7.6 Hz, 2H), 7.54 (t, J = 7.3 Hz, 1H), 7.45–7.38 (m, 3H), 7.26 (t, J = 8.1 Hz, 1H), 7.21–7.20 (m, 2H), 7.14–7.10 (m, 2H), 7.02–6.98 (m, 2H), 5.07 (t, J = 6.8 Hz, 1H), 3.81 (dd, J = 16.8, 8.5 Hz, 1H), 3.69 (dd, J = 16.8, 6.0 Hz, 1H), 2.31 (s, 3H); 13C-NMR (CDCl3) δ 197.6, 151.5, 136.9, 136.8, 135.9, 133.4, 130.2, 129.7, 129.6, 128.9, 128.4, 127.0, 126.6, 122.6, 122.3, 119.9, 119.5, 117.0, 111.3, 45.1, 34.0, 17.7; MS (EI) m/z (relative intensity) 384 (M+, 22), 367 (25), 265 (23), 247 (60), 221 (42), 204 (18); HRMS (EI) m/z calcd for C24H20N2O3 (M+) 384.1474, found 384.1476.
3-(2,5-Dimethyl-1H-indol-3-yl)-3-(2-nitrophenyl)-1-phenylpropan-1-one (3u): Purified by column chromatography using 1:4 ethyl acetate and hexane. After concentration in vacuo a green solid with a melting point of 119–121 °C was obtained; 1H-NMR (CDCl3) δ 7.88 (dd, J = 7.8, 1.3 Hz, 2H), 7.71–7.67 (m, 3H), 7.54–7.48 (m, 2H), 7.40 (t, J = 7.9 Hz, 2H), 7.32 (dt, J = 8.4, 1.2 Hz, 1H), 7.11–7.09 (m, 2H), 6.87 (d, J = 8.1 Hz, 1H), 5.69 (t, J = 7.1 Hz, 1H), 3.94 (dd, J = 17.0, 7.6 Hz, 1H), 3.84 (dd, J = 17.0, 6.8 Hz, 1H), 2.34 (s, 3H), 2.33 (s, 3H); 13C-NMR (CDCl3) δ 198.0, 150.3, 138.7, 137.1, 133.9, 133.2, 133.2, 132.3, 129.5, 128.7, 128.7, 128.2, 127.9, 127.2, 124.8, 122.6, 118.5, 111.0, 110.5, 43.4, 33.1, 21.9, 12.3; MS (EI) m/z (relative intensity) 398 (M+, 25), 262 (53), 261 (36), 207 (33), 160 (48), 105 (100); HRMS (EI) m/z calcd for C25H22N2O3 (M+) 398.1630, found 398.1629.
3-(2,5-Dimethyl-1H-indol-3-yl)-3-(3-methyl-2-nitrophenyl)-1-phenylpropan-1-one (3v): Purified by column chromatography using 1:4 ethyl acetate and hexane. After concentration in vacuo a pale yellow solid with a melting point of 173–175 °C was obtained; 1H-NMR (CDCl3) δ 77.88–7.86 (m, 2H), 7.63 (s, 1H), 7.55–7.50 (m, 2H), 7.40 (t, J = 7.8 Hz, 2H), 7.31 (t, J = 7.8 Hz, 1H), 7.20 (s, 1H), 7.13 (d, J = 7.6 Hz, 1H), 7.09 (d, J = 8.2 Hz, 1H), 6.87 (d, J = 8.2 Hz, 1H), 5.18 (dd, J = 8.2, 6.2 Hz, 1H), 3.96 (dd, J = 16.9, 8.4 Hz, 1H), 3.80 (dd, J = 16.9, 6.2 Hz, 1H), 2.35 (s, 3H), 2.32 (s, 3H), 2.23 (s, 3H); 13C-NMR (CDCl3) δ 197.9, 151.8, 137.1, 135.7, 133.9, 133.2, 133.0, 130.0, 129.9, 129.4, 128.7, 128.5, 128.2, 127.6, 126.2, 122.5, 118.5, 110.7, 110.4 ,43.2, 33.0, 21.9, 17.6, 12.1; MS (EI) m/z (relative intensity) 412 (M+, 25), 275 (39), 247 (16), 221 (50), 160 (37), 105 (100); HRMS (EI) m/z calcd for C26H24N2O3 (M+) 412.1787, found 412.1780.

3.3. General Procedure for Reductive Cyclization (Synthesis of 4a4u)

To a stirred solution of 3a (1 mmol) in ethanol (10 mL), powdered Fe (6 mmol) and HCl (1 mmol) were added and the reaction mixture was kept stirring at reflux until TLC analysis showed complete consumption of 3a. Then, the reaction mixture was quenched by saturated aq. NaHCO3, filtered by celite and concentrated, then the residue was extracted with ethyl acetate three times (10 mL each time). The combined organic layers were dried over magnesium sulfate, filtered and concentrated. The residue was purified by recrystallization or flash chromatography (EtOAc/hexane) to afford the final product 4a. (The 1H-, 13C-NMR spectra of the compounds (4a4u) was showed in Supplementary).
4-(1H-Indol-3-yl)-2-phenylquinoline (4a): Pale yellow crystalline solid (crystallized from ethyl acetate and hexane) with a melting point of 229–231 °C; IR (KBr): 3200, 3050, 1591, 1546, 1498, 1237, 828, 741 cm−1. 1H-NMR (DMSO-d6) δ 11.78 (s, 1H), 8.31 (d, J = 7.2 Hz, 2H), 8.17–8.13 (m, 3H), 7.90 (d, J = 1.8 Hz, 1H), 7.79 (t, J = 7.3 Hz, 1H), 7.59–7.48 (m, 6H), 7.23 (t, J = 7.3 Hz, 1H), 7.11 (t, J = 7.5 Hz, 1H); 13C-NMR (DMSO-d6) δ 155.9, 148.5, 142.9, 139.0, 136.6, 129.7, 129.6, 129.4, 128.8, 127.3, 126.6, 126.2, 126.1, 126.0, 125.7, 121.9, 120.0, 119.1, 118.5, 112.2, 112.0; MS (EI) m/z (relative intensity) 320 (M+, 100); HRMS (EI) m/z calcd for C23H16N2 (M+) 320.1313, found 320.1307.
6-Fluoro-4-(1H-indol-3-yl)-2-phenylquinoline (4b): Purified by column chromatography using 1:4 ethyl acetate and hexane. After concentration in vacuo a pale brown solid with a melting point of 154–156 °C was obtained; IR (KBr): 3320, 3048, 1588, 1545, 1494,1240, 830, 750 cm−1. 1H-NMR (DMSO-d6) δ 11.81 (s, 1H), 8.31–8.28 (m, 2H), 8.21 (dd, J = 17.4, 5.7 Hz, 1H), 8.16 (s, 1H), 7.94 (d, J = 2.4 Hz, 1H), 7.79 (dd, J = 10.5, 2.6 Hz, 1H), 7.70 (dt, J = 8.4, 2.7 Hz, 1H), 7.60–7.48 (m, 5H), 7.24 (t, J = 7.6 Hz, 1H), 7.13 (t, J = 7.8 Hz, 1H); 13C-NMR (DMSO-d6) δ 159.3 (d, JC–F = 244 Hz), 155.5 (d, JC–F = 3 Hz), 145.7, 142.5 (d, JC–F = 3 Hz), 138.7, 136.6, 132.5 (d, JC–F = 5 Hz), 129.5, 128.8, 127.2, 126.7, 126.4 (d, JC–F = 9 Hz), 126.0, 122.0, 120.1, 119.6 (d, JC–F = 25 Hz), 119.1, 118.9, 112.3, 111.5, 109.3 (d, JC–F = 23 Hz); MS (EI) m/z (relative intensity) 338 (M+, 100), 337 (65), 285 (24), 149 (87), 105 (30); HRMS (EI) m/z calcd for C23H15N2F (M+) 338.1219, found 338.1213.
6-Chloro-4-(1H-indol-3-yl)-2-phenylquinoline (4c): Purified by column chromatography using 1:4 ethyl acetate and hexane. After concentration in vacuo a pale yellow solid with a melting point of 209–211 °C was obtained; 1H-NMR (DMSO-d6) δ 11.83 (s, 1H), 8.29 (d, J = 8.6 Hz, 2H), 8.16–8.13 (m, 2H), 8.10 (d, J = 1.8 Hz, 1H), 7.94 (s, 1H), 7.77 (dd, J = 8.9, 2.1 Hz, 1H), 7.60–7.48 (m, 5H), 7.24 (t, J = 7.3 Hz, 1H), 7.12 (t, J = 7.7 Hz, 1H); 13C-NMR (DMSO-d6) δ 156.4, 147.0, 142.4, 138.6, 136.6, 131.8, 130.6, 130.2, 129.7, 128.8, 127.3, 126.9, 126.5, 126.1, 124.8, 122.1, 120.2, 119.4, 118.9, 112.3, 111.4; MS (EI) m/z (relative intensity) 356 ([M + 2]+, 8), 354 (M+, 24), 353 (12), 149 (100); HRMS (EI) m/z calcd for C23H15N2Cl (M+) 354.0924, found 354.0919.
6-Bromo-4-(1H-indol-3-yl)-2-phenylquinoline (4d): Purified by column chromatography using 1:4 ethyl acetate and hexane. After concentration in vacuo a yellow solid with a melting point of 214–216 °C was obtained; 1H-NMR (DMSO-d6) δ 11.83 (s, 1H), 8.28 (d, J = 7.4 Hz, 2H), 8.26 (d, J = 1.8 Hz, 1H), 8.15 (s, 1H), 8.06 (d, J = 8.9 Hz, 1H), 7.93 (d, J = 2.1 Hz, 1H), 7.86 (dd, J = 8.9, 1.8 Hz, 1H), 7.60 (d, J = 8.1 Hz, 1H), 7.54–7.46 (m, 4H), 7.24 (t, J = 7.3 Hz, 1H), 7.11 (t, J = 7.6 Hz, 1H); 13C-NMR (DMSO-d6) δ 156.5, 147.2, 142.3, 138.6, 136.6, 132.7, 131.9, 129.7, 128.8, 128.1, 127.4, 127.0, 126.9, 126.1, 122.1, 120.2, 119.4, 119.2, 118.9, 112.3, 111.4; MS (EI) m/z (relative intensity) 400 ([M + 2]+, 100), 398 (M+, 98), 319 (34), 318 (27); HRMS (EI) m/z calcd for C23H15N2Br (M+) 398.0419, found 398.0417.
2-(2-Chlorophenyl)-4-(1H-indol-3-yl)quinoline (4e): Purified by column chromatography using 1:4 ethyl acetate and hexane. After concentration in vacuo a pale yellow solid with a melting point of 242–244 °C was obtained; 1H-NMR (DMSO-d6) δ 11.78 (s, 1H), 8.26 (d, J = 8.2 Hz, 1H), 8.13 (d, J = 8.2 Hz, 1H), 7.88 (d, J = 2.6 Hz, 1H), 7.85- 7.77 (m, 3H), 7.65–7.51 (m, 6H), 7.22 (t, J = 7.3 Hz, 1H), 7.12 (t, J = 7.5 Hz, 1H); 13C-NMR (DMSO-d6) δ 156.3, 148.4, 141.7, 139.3, 136.6, 131.8, 131.3, 130.2, 129.8, 129.6, 129.6, 127.4, 126.8, 126.6, 126.1, 126.0, 125.4, 122.0, 122.0, 120.1, 118.8, 112.2, 111.4; MS (EI) m/z (relative intensity) 356 ([M + 2]+, 42), 354 (M+, 100); HRMS (EI) m/z calcd for C23H15N2Cl (M+) 354.0924, found 354.0924.
2-(2-Bromophenyl)-4-(1H-indol-3-yl)quinoline (4f): Purified by column chromatography using 1:4 ethyl acetate and hexane). After concentration in vacuo a pale yellow solid with a melting point of 236–238 °C was obtained; 1H-NMR (DMSO-d6) δ 11.80 (s, 1H), 8.27 (d, J = 7.9 Hz, 1H), 8.13 (d, J = 8.1 Hz, 1H), 7.88 (d, J = 2.6 Hz, 1H), 7.83–7.78 (m, 3H), 7.73 (dd, J = 7.6, 1.6 Hz, 1H), 7.65–7.62 (m, 2H), 7.58–7.52 (m, 2H), 7.41 (dt, J = 7.8, 1.8 Hz, 1H), 7.22 (t, J = 7.3 Hz, 1H), 7.11 (t, J = 7.3 Hz, 1H); 13C-NMR (DMSO-d6) δ 157.8, 148.3, 141.7, 141.3, 136.6, 132.9, 131.7, 130.3, 129.6, 129.6, 127.8, 126.8, 126.6, 126.1, 126.0, 125.4, 122.0, 122.0, 121.1, 120.1, 118.9, 112.2, 111.4; MS (EI) m/z (relative intensity) 400 ([M + 2]+, 100), 399 ([M + 1]+, 95), 398 (M+, 90), 338 (13), 319 (34), 204 (22), 159 (12); HRMS (EI) m/z calcd for C23H15N2Br (M+) 398.0419, found 398.0412.
4-(1H-Indol-3-yl)-2-p-tolylquinoline (4g): Purified by column chromatography using 1:4 ethyl acetate and hexane. After concentration in vacuo an orange solid with s melting point of 277–279 °C was obtained; IR (KBr): 3300, 3040, 1585, 1439, 1364, 1240, 814, 734 cm−1. 1H-NMR (DMSO-d6) δ 11.74 (s, 1H), 8.21 (d, J = 8.1 Hz, 2H), 8.13 (d, J = 8.7 Hz, 2H), 8.09 (s, 1H), 7.88 (d, J = 2.2 Hz, 1H), 7.78 (t, J = 6.8 Hz, 1H), 7.57–7.51 (m, 3H), 7.37 (d, J = 8.0 Hz, 2H), 7.23 (t, J = 7.4 Hz, 1H), 7.11 (t, J = 7.4 Hz, 1H), 2.40 (s, 3H); 13C-NMR (DMSO-d6) δ 155.8, 148.5, 142.8, 139.0, 136.5, 136.2, 129.6, 129.6, 129.4, 127.1, 126.5, 126.2, 126.0, 125.9, 125.6, 121.9, 120.0, 119.1, 118.3, 112.2, 112.0, 20.9; MS (EI) m/z (relative intensity) 334 (M+, 100); HRMS (EI) m/z calcd for C24H18N2 (M+) 334.1470, found 334.1469.
4-(1H-Indol-3-yl)-2-(4-methoxyphenyl)quinoline (4h): Purified by column chromatography using 1:4 ethyl acetate and hexane. After concentration in vacuo a pale yellow solid with a melting point of 231–233 °C was obtained; 1H-NMR (DMSO-d6) δ 11.74 (s, 1H), 8.28 (td, J = 8.8, 2.8 Hz, 2H), 8.11 (ddd, J = 8.6, 2.3, 1.0 Hz, 2H), 8.08 (s, 1H), 7.88 (d, J = 2.6 Hz, 1H), 7.77 (ddd, J = 8.1, 7.0, 1.1 Hz, 1H), 7.57 (d, J = 8.1 Hz, 1H), 7.53–7.50 (m, 2H), 7.23 (ddd, J = 7.8, 7.2, 0.6 Hz, 1H), 7.13–7.09 (m, 3H), 3.85 (s, 3H); 13C-NMR (DMSO-d6) δ 160.5, 155.5, 148.5, 142.6, 136.5, 131.4, 129.5, 129.5, 128.6, 126.4, 126.3, 125.9, 125.6, 125.4, 121.8, 119.9, 119.1, 118.1, 114.1, 112.1, 112.1, 55.2; MS (EI) m/z (relative intensity) 350 (M+, 100), 349 (64); HRMS (EI) m/z calcd for C24H18N2O (M+) 350.1419, found 350.1412.
2-(Benzo[d][1,3]dioxol-5-yl)-4-(1H-indol-3-yl)quinoline (4i): Purified by column chromatography using 1:3 ethyl acetate and hexane. After concentration in vacuo a yellow solid with a melting point of 237–239 °C was obtained; 1H-NMR (DMSO-d6) δ 11.74 (s, 1H), 8.10 (d, J = 8.4 Hz, 2H), 8.06 (s, 1H), 7.89–7.85 (m, 3H), 7.77 (t, J = 7.2 Hz, 1H), 7.57–7.50 (m, 3H), 7.22 (t, J = 7.4 Hz, 1H), 7.13–7.07 (m, 2H), 6.12 (s, 2H); 13C-NMR (DMSO-d6) δ 155.3, 148.6, 148.4, 148.1, 142.8, 136.6, 133.4, 129.6, 129.6, 126.6, 126.3, 126.0, 125.8, 125.6, 121.9, 121.7, 120.0, 119.2, 118.3, 112.2, 112.1, 108.5, 107.3, 101.4; MS (EI) m/z (relative intensity) 364 (M+, 100); HRMS (EI) m/z calcd for C26H14N2O2 (M+) 364.1212, found 364.1218.
4-(1H-Indol-3-yl)-2-(naphthalen-2-yl)quinoline (4j): Purified by column chromatography using 1:4 ethyl acetate and hexane. After concentration in vacuo an orange solid with a melting point > 300 °C was obtained; 1H-NMR (DMSO-d6) δ 11.77 (s, 1H), 8.87 (s, 1H), 8.54 (d, J = 8.5 Hz, 1H), 8.32 (s, 1H), 8.21 (d, J = 8.4 Hz, 1H), 8.16 (d, J = 8.3 Hz, 1H), 8.13–8.09 (m, 2H), 8.01–7.99 (m, 1H), 7.93 (s, 1H), 7.83 (t, J = 7.2 Hz, 1H), 7.59–7.55 (m, 5H), 7.24 (t, J = 7.4 Hz, 1H), 7.13 (t, J = 7.4 Hz, 1H); 13C-NMR (DMSO-d6) δ 155.7, 148.5, 143.0, 136.6, 136.3, 133.4, 133.1, 129.7, 129.7, 128.8, 128.3, 127.5, 126.9, 126.8, 126.6, 126.5, 126.3, 126.2, 126.1, 125.8, 124.8, 121.9, 120.0, 119.1, 118.8, 112.2, 112.0; HRMS (ESI) m/z calcd for C27H19N2 ([M + H]+) 371.1548, found 371.1554.
4-(1H-Indol-3-yl)-2-(thiophen-2-yl)quinoline (4k): Purified by column chromatography using 1:4 ethyl acetate and hexane. After concentration in vacuo a yellow solid with a melting point of 201–203 °C was obtained; IR (KBr): 3300, 3054, 1587, 1545, 1425, 1370, 1240, 811, 744 cm−1. 1H-NMR (DMSO-d6) δ 11.75 (s, 1H), 8.11 (s, 1H), 8.08 (d, J = 8.4 Hz, 1H), 8.04 (d, J = 8.3 Hz, 1H), 8.01 (d, J = 3.7 Hz, 1H), 7.87 (d, J = 2.5 Hz, 1H), 7.78–7.73 (m, 2H), 7.57 (d, J = 8.2 Hz, 1H), 7.53–7.50 (m, 2H), 7.25–7.20 (m, 2H), 7.11 (t, J = 7.8 Hz, 1H); 13C-NMR (DMSO-d6) δ 151.6, 148.2, 145.0, 142.8, 136.5, 129.8, 129.3, 129.0, 128.5, 126.8, 126.6, 126.3, 126.1, 125.8, 125.8, 121.9, 120.0, 119.1, 117.4, 112.2, 111.7; MS (EI) m/z (relative intensity) 326 (M+, 100), 163 (10), 84 (13), 66 (15); HRMS (EI) m/z calcd for C21H14N2S (M+) 326.0878, found 326.0883.
4-(5-Fluoro-1H-indol-3-yl)-2-phenylquinoline (4l): Pale yellow crystalline solid (crystallized from ethyl acetate and hexane) with a melting point of 236–238 °C; 1H-NMR (DMSO-d6) δ 11.87 (s, 1H), 8.32 (d, J = 7.4 Hz, 2H), 8.16 (d, J = 8.4 Hz, 1H), 8.11–8.10 (m, 2H), 7.97 (d, J = 2.3 Hz, 1H), 7.80 (t, J = 7.6 Hz, 1H), 7.84–7.59 (m, 5H), 7.22 (dd, J = 9.9, 1.8 Hz, 1H), 7.08 (dt, J = 9.1, 2.1 Hz, 1H); 13C-NMR (DMSO-d6) δ 157.6 (d, JC–F = 232 Hz), 155.9, 128.5, 142.4, 139.0, 133.3, 129.8, 129.7, 129.4, 128.8, 128.6, 127.3, 126.6 (d, JC–F = 10 Hz), 126.2, 125.9, 125.6, 118.6, 113.3 (d, JC–F = 10 Hz), 112.3 (d, JC–F = 4 Hz), 110.3 (d, JC–F = 26 Hz), 103.9 (d, JC–F = 23 Hz); MS (EI) m/z (relative intensity) 338 (M+, 100); HRMS (EI) m/z calcd for C23H15N2F (M+) 338.1219, found 338.1210.
4-(5-Chloro-1H-indol-3-yl)-2-phenylquinoline (4m): Yellow crystalline solid (crystallized from ethyl acetate and hexane) with a melting point of 204–206 °C; 1H-NMR (DMSO-d6) δ 11.97 (s, 1H), 8.32 (d, J = 7.4 Hz, 2H), 8.16 (d, J = 8.4 Hz, 1H), 8.12 (s, 1H), 8.07 (d, J = 8.3 Hz, 1H), 7.98 (s, 1H), 7.80 (t, J = 7.7 Hz, 1H), 7.60–7.48 (m, 5H), 7.46 (d J = 1.0 Hz, 1H), 7.20 (dd, J = 8.6, 1.4 Hz, 1H); 13C-NMR (DMSO-d6) δ 155.9, 148.5, 142.2, 139.0, 135.1, 129.8, 129.7, 129.4, 128.7, 128.2, 127.5, 127.3, 126.2, 125.8, 125.7, 124.7, 122.0, 118.8, 118.3, 113.8, 111.9; MS (EI) m/z (relative intensity) 356 ([M + 2]+, 33), 354 (M+, 100); HRMS (EI) m/z calcd for C23H15N2Cl (M+) 354.0924, found 354.0924.
4-(5-Bromo-1H-indol-3-yl)-2-phenylquinoline (4n): Purified by column chromatography using 1:4 ethyl acetate and hexane). After concentration in vacuo a pale green solid with a melting point of 255–257 °C was obtained; 1H-NMR (DMSO-d6) δ 12.00 (s, 1H), 8.32 (d, J = 7.3 Hz, 2H), 8.16 (d, J = 8.4 Hz, 1H), 8.12 (s, 1H), 8.07 (d, J = 8.2 Hz, 1H), 7.97 (s, 1H), 7.78 (t, J = 7.5 Hz, 1H), 7.61–7.46 (m, 6H), 7.34 (d, J = 8.6 Hz, 1H); 13C-NMR (DMSO-d6) δ 155.9, 148.4, 142.1, 138.9, 135.3, 129.8, 129.7, 129.4, 128.8, 128.1, 128.0, 127.3, 126.2, 125.8, 125.7, 124.5, 121.2, 118.8, 114.2, 112.5, 111.7; MS (EI) m/z (relative intensity) 400 ([M + 2]+, 85), 398 (M+, 100); HRMS (EI) m/z calcd for C23H15N2Br (M+) 398.0419, found 398.0425.
4-(5-Methoxy-1H-indol-3-yl)-2-phenylquinoline (4o): White crystalline solid (crystallized from ethyl acetate and hexane) with a melting point of 183–185 °C; 1H-NMR (DMSO-d6) δ 11.63 (s, 1H), 8.31 (dd, J = 7.2 Hz, 2H), 8.15 (d, J = 8.7 Hz, 2H), 8.13 (s, 1H), 7.85 (d, J = 2.6 Hz, 1H), 7.79 (dt, J = 7.0, 1.8 Hz, 1H), 7.59–7.54 (m, 3H), 7.52–7.46 (m, 2H), 6.96 (d, J = 2.3 Hz, 1H), 6.88 (dd, J = 8.8, 2.4 Hz, 1H), 3.67 (s, 3H); 13C-NMR (DMSO-d6) δ 155.9, 154.1, 148.6, 143.1, 139.0, 131.7, 129.8, 129.7, 129.4, 128.8, 127.3, 127.2, 126.6, 126.2, 126.0 125.7, 118.4, 113.0,112.1, 112.0, 100.9, 55.3; MS (EI) m/z (relative intensity) 350 (M+, 100), 349 (18); HRMS (EI) m/z calcd for C24H18N2O (M+) 350.1419, found 350.1422.
4-(7-Methyl-1H-indol-3-yl)-2-phenylquinoline (4p): Purified by column chromatography using 1:4 ethyl acetate and hexane. After concentration in vacuo a pale yellow solid with a melting point of 163–165 °C was obtained; 1H-NMR (DMSO-d6) δ 11.74 (s, 1H), 8.30 (d, J = 7.3 Hz, 2H), 8.15 (d, J = 8.7 Hz, 2H), 8.12 (s, 1H), 7.88 (d, J = 2.6 Hz, 1H), 7.79 (t, J = 7.7 Hz, 1H), 7.58–7.48 (m, 4H), 7.37–7.34 (m, 1H), 7.03–7.00 (m, 2H), 2.58 (s, 3H); 13C-NMR (DMSO-d6) δ 155.8, 148.5, 143.1, 139.0, 136.1, 129.7, 129.6, 129.4, 128.8, 127.3, 126.3, 126.1, 126.0, 126.0, 125.7, 122.4, 121.4, 120.2, 118.6, 116.7, 112.5, 16.8; MS (EI) m/z (relative intensity) 334 (M+, 100), 333 (68); HRMS (EI) m/z calcd for C24H18N2 (M+) 334.1470 found 334.1477.
4-(1-Methyl-1H-indol-3-yl)-2-phenylquinoline (4q): White crystalline solid (from ethyl acetate and hexane) with a melting point of 138–140 °C; 1H-NMR (DMSO-d6) δ 8.30 (d, J = 8.0 Hz, 2H), 8.17 (dd, J = 10.9, 8.8 Hz, 2H), 8.11 (s, 1H), 7.91 (s, 1H), 7.80 (dd, J = 8.0, 7.1 Hz, 1H), 7.61 (d, J = 8.3 Hz, 1H), 7.59–7.49 (m, 5H), 7.30 (t, J = 7.4 Hz, 1H), 7.16 (t, J = 7.6 Hz, 1H), 3.96 (s, 3H); 13C-NMR (DMSO-d6) δ 155.8, 148.5, 142.4, 139.0, 137.0, 130.7, 129.7, 129.7, 129.4, 128.8, 127.2, 126.5, 126.1, 125.9, 125.6, 122.0, 120.3, 119.3, 118.4, 111.0, 110.5, 32.8; MS (EI) m/z (relative intensity) 334 (M+, 100), 333 (61); HRMS (EI) m/z calcd for C24H18N2 (M+) 334.1470, found 334.1469.
4-(2-Methyl-1H-indol-3-yl)-2-phenylquinoline (4r): Purified by column chromatography using 1:4 ethyl acetate and hexane. After concentration in vacuo a brown solid with a melting point of 98–100 °C was obtained; 1H-NMR (DMSO-d6) δ 8.73 (s, 1H), 8.29 (d, J = 8.4 Hz, 1H), 8.16 (d, J = 7.6 Hz, 2H), 7.87 (s, 1H), 7.81 (d, J = 8.3 Hz, 1H), 7.68 (t, J = 7.9 Hz, 1H), 7.47 (t, J = 7.3 Hz, 1H), 7.42–7.29 (m, 4H), 7.17 (t, J = 7.3 Hz, 1H), 7.07 (t, J = 7.4 Hz, 1H), 2.21 (s, 3H); 13C-NMR (DMSO-d6) δ 157.4, 149.1, 143.5, 140.0, 135.6, 133.8, 129.9, 129.8, 129.4, 129.0, 128.7, 127.9, 127.2, 126.8, 126.0, 121.9, 121.2, 120.3, 119.1, 110.9, 110.8, 12.7; MS (EI) m/z (relative intensity) 334 (M+, 100), 333 (55), HRMS (EI) m/z calcd for C24H18N2 (M+) 334.1470, found 334.1464.
2-Phenyl-4-(2-phenyl-1H-indol-3-yl)quinoline (4s): Purified by column chromatography using 1:4 ethyl acetate and hexane. After concentration in vacuo an orange solid with a melting point of 282–284 °C was obtained; 1H-NMR (DMSO-d6) δ 12.00 (s, 1H), 8.21 (d, J = 7.3 Hz, 2H), 8.15 (d, J = 8.4 Hz, 1H), 8.04 (s, 1H), 7.72–7.65 (m, 2H), 7.60 (d, J = 8.1 Hz, 1H), 7.50–7.42 (m, 5H), 7.22 (t, J = 7.7 Hz, 1H), 7.26–7.16 (m, 5H), 7.01 (t, J = 7.5 Hz, 1H); 13C-NMR (DMSO-d6) δ 155.9, 148.4, 143.6, 138.7, 136.3, 135.9, 131.9, 129.7, 129.7, 129.5, 128.9, 128.8, 128.6, 127.7, 127.5, 127.2, 126.4, 126.1, 126.0, 122.4, 120.6, 120.1, 118.7, 111.7, 109.1; MS (EI) m/z (relative intensity) 396 (M+, 100), 395 (36), 193 (14); HRMS (EI) m/z calcd for C29H20N2 (M+) 396.1626, found 396.1634.
4-(1H-Indol-3-yl)-8-methyl-2-phenylquinoline (4t): Purified by column chromatography using 1:4 ethyl acetate and hexane. After concentration in vacuo a pale orange solid with a melting point of 102–104 °C was obtained; 1H-NMR (CDCl3) δ 11.75 (s, 1H), 8.35 (d, J = 7.5 Hz, 2H), 8.13 (s, 1H), 7.99 (d, J = 8.3 Hz, 1H), 7.86 (d, J = 2.3 Hz, 1H), 7.63–7.46 (m, 6H), 7.40 (t, J = 8.1 Hz, 1H), 7.22 (t, J = 7.2 Hz, 1H), 7.10 (t, J = 7.4 Hz, 1H), 2.87 (s, 3H); 13C-NMR (CDCl3) δ 154.4, 147.3, 143.2, 139.3, 137.0, 136.6, 129.6, 129.3, 128.8, 127.2, 126.5, 126.4, 125.7, 124.0, 121.9, 120.0, 119.1, 118.3, 112.4, 112.2, 18.2; MS (EI) m/z (relative intensity) 334 (M+, 100), 333 (30), 219 (30); HRMS (EI) m/z calcd for C24H18N2 (M+) 334.1470, found 334.1471.
4-(2,5-Dimethyl-1H-indol-3-yl)-2-phenylquinoline (4u): Purified by column chromatography using 1:4 ethyl acetate and hexane. After concentration in vacuo an orange solid with a melting point of 181–183 °C was obtained; 1H-NMR (CDCl3) δ 8.27 (d, J = 8.4 Hz, 1H), 8.20 (d, J = 7.4 Hz, 3H), 7.90 (s, 1H), 7.84 (d, J = 8.3 Hz, 1H), 7.73 (ddd, J = 8.1, 7.1, 1.0 Hz, 1H), 7.54 (t, J = 7.2 Hz, 2H), 7.49–7.41 (m, 2H), 7.31 (d, J = 8.2 Hz, 1H), 7.12 (s, 1H), 7.05 (d, J = 8.2 Hz, 1H), 2.38 (s, 3H), 2.37 (s, 3H); 13C-NMR (CDCl3) δ 157.3, 149.2, 143.4, 140.3, 133.9, 133.6, 130.3, 129.9, 129.7, 129.4, 129.1, 129.0, 127.9, 127.3, 126.8, 126.1, 123.7, 121.2, 119.0, 110.9, 110.4, 21.7, 13.0; MS (EI) m/z (relative intensity) 348 (M+, 100), 347 (35), 166 (11); HRMS (EI) m/z calcd for C25H20N2 (M+) 348.1626, found 348.1632.
2-Phenylquinoline (5a): Purified by column chromatography using 1:6 ethyl acetate and hexane. After concentration in vacuo a white solid with a melting point of 84–86 °C was obtained; 1H-NMR (CDCl3) δ 8.46 (d, J = 8.7 Hz, 1H), 8.28 (d, J = 7.1 Hz, 2H), 8.15 (d, J = 8.7 Hz, 1H), 8.08 (d, J = 7.8 Hz, 1H), 8.00 (d, J = 7.8 Hz, 1H), 7.79 (ddd, J = 8.2, 7.0, 1.2 Hz, 1H), 7.62–7.45 (m, 4H); 13C-NMR (CDCl3) δ 156.1, 147.6, 138.7, 137.2, 130.0, 129.6, 129.1, 128.9, 127.8, 127.2, 127.0, 126.5, 118.8; MS (EI) m/z (relative intensity) 205 (M+, 100), 204 (78); HRMS (EI) m/z calcd for C15H11N (M+) 205.0891, found 205.0889.
8-Methyl-2-phenylquinoline (5v): Purified by column chromatography using 1:6 ethyl acetate and hexane. After concentration in vacuo an orange oil was obtained; 1H-NMR (CDCl3) δ 8.30 (d, J = 7.5 Hz, 2H), 8.18 (d, J = 8.5 Hz, 1H), 7.91 (d, J = 8.5 Hz, 1H), 7.67 (d, J = 8.0 Hz, 1H), 7.61–7.54 (m, 3H), 7.49 (t, J = 7.1 Hz, 1H), 7.43 (t, J = 7.5 Hz, 1H), 2.94 (s, 3H); 13C-NMR (CDCl3) δ 155.7, 147.4, 140.1, 137.9, 137.1, 129.9, 129.4, 129.0, 127.7, 127.3, 126.2, 125.6, 118.4, 18.1; MS (EI) m/z (relative intensity) 219 (M+, 100); HRMS (EI) m/z calcd for C16H13N (M+) 219.1048, found 219.1044.

4. Conclusions

In summary, we have successfully developed a strategy for the synthesis of 4-indolylquinoline derivatives from 2-nitrochalcone derivatives in two steps. The process involves as a first step the Michael addition of indole to nitrochalcones under solvent free conditions catalyzed by sulfamic acid and the second step is a reductive cyclization of the 3-(1H-indol-3-yl)-3-(2-nitrophenyl)-1-phenylpropan-1-one derivatives to 4-indolylquinoline derivatives via reductive cyclization by Fe/HCl in ethanol. A wide substrate scope, clean reactions and high yields of the products are the main merits of this strategy. This procedure offers an easy, convenient and alternative method to existing methodologies for the synthesis of indolylquinoline derivatives.

Supplementary Materials

Supplementary materials can be accessed at: https://www.mdpi.com/1420-3049/20/12/19862/s1.

Acknowledgments

Financial support for this work by the Ministry of Science and Technology of China (MOST 103-2113-M-003-008-MY3), National Taiwan Normal University (103-07-C) and Instrumentation Centre at National Taiwan Normal University is gratefully acknowledged. The authors are grateful to Hsiu-Ni Huan and Chiu-Hui He for providing mass and NMR spectral data presented in this paper.

Author Contributions

Ching-Fa Yao, Wen-Chang Chen, Chan-Chieh Lin, conceived and designed the experiments; Wen-Chang Chen, Chan-Chieh Lin, Chun-Wei Kuo, and Chia-Yu Huang performed the experiments; Chia-Yu Huang, Chun-Wei Kuo analyzed the data; Veerababurao Kavala and Ching-Fa Yao wrote the paper.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Van Order, R.B.; Lindwall, H.G. Indole. Chem. Rev. 1942, 30, 69–96. [Google Scholar]
  2. Finlayson, R.; Pearce, A.N.; Page, M.J.; Kaiser, M.; Bourguet-Kondracki, M.L.; Harper, J.L.; Webb, V.L.; Copp, B.R. Didemnidines A and B, Indole Spermidine Alkaloids from the New Zealand Ascidian Didemnum sp. J. Nat. Prod. 2011, 74, 888–892. [Google Scholar] [CrossRef] [PubMed]
  3. Koyama, K.; Hirasawa, Y.; Nugroho, A.E.; Hosoya, T.; Hoe, T.C.; Chan, K.L.; Morita, H. Alsmaphorazines A and B, Novel Indole Alkaloids from Alstonia pneumatophore. Org. Lett. 2010, 12, 4188–4191. [Google Scholar] [CrossRef] [PubMed]
  4. Afzal, O.; Kumar, S.; Haider, M.R.; Ali, M.R.; Kumar, R.; Jaggi, M.; Bawa, S. A review on anticancer potential of bioactive heterocycle quinoline. Eur. J. Med. Chem. 2015, 97, 871–910. [Google Scholar] [CrossRef] [PubMed]
  5. Chung, P.Y.; Bian, Z.X.; Pun, H.Y.; Chan, D.; Chan, A.S.C.; Chui, C.H.; Tang, J.C.O.; Lam, K.H. Recent advances in research of natural and synthetic bioactive quinolones. Future Med. Chem. 2014, 7, 947–967. [Google Scholar]
  6. Michael, J.P. Quinoline, quinazoline and acridone alkaloids. Nat. Prod. Rep. 2005, 22, 627–646. [Google Scholar] [CrossRef] [PubMed]
  7. Liu, C.Y.; Wu, P.T.; Wang, J.P.; Fan, P.W.; Hsieh, C.H.; Su, C.L.; Chiu, C.C.; Yao, C.F.; Fang, K. An indolylquinoline derivative promotes apoptosis in human lung cancer cells by impairing mitochondrial functions. Apoptosis 2015, 20, 1471–1482. [Google Scholar] [CrossRef] [PubMed]
  8. Bhowal, S.K.; Lala, S.; Hazra, A.; Paira, P.; Banerjee, S.; Mondal, N.B.; Chakraborty, S. Synthesis and assessment of fertility-regulating potential of 2-(2″-chloroacetamidobenzyl)-3-(3′-indolyl) quinoline in adult rats as a male contraceptive agent. Contraception 2008, 77, 214–222. [Google Scholar] [CrossRef] [PubMed]
  9. Kuethe, J.T.; Wong, A.; Qu, C.; Smitrovich, J.; Davies, I.W.; Hughes, D.L. Synthesis of 5-Substituted-1H-indol-2-yl-1H-quinolin-2-ones:  A Novel Class of KDR Kinase Inhibitors. J. Org. Chem. 2005, 70, 2555–2567. [Google Scholar] [CrossRef] [PubMed]
  10. Payack, J.F.; Vazquez, E.; Matty, L.; Kress, M.H.; McNamara, J. A Concise Synthesis of a Novel Antiangiogenic Tyrosine Kinase Inhibitor. J. Org. Chem. 2005, 70, 175–178. [Google Scholar] [CrossRef] [PubMed]
  11. Maguire, M.P.; Sheets, K.R.; McVety, K.; Spada, A.P.; Zilbersteint, A. A New Series of PDGF Receptor Tyrosine Kinase Inhibitors: 3-Substituted Quinoline Derivatives. J. Med. Chem. 1994, 37, 2129–2137. [Google Scholar] [CrossRef]
  12. Oliva, B.; Miller, K.; Caggiano, N.; O’Neill, A.J.; Cuny, G.D.; Hoemann, M.Z.; Hauske, J.R.; Chopra, I. Biological Properties of Novel Antistaphylococcal Quinoline-Indole Agents. Antimicrob. Agents Chemother. 2003, 47, 458–466. [Google Scholar] [CrossRef] [PubMed]
  13. Hoemam, M.Z.; Kumaravel, G.; Xie, R.L.; Rossi, R.F.; Meyer, S.; Sidhu, A.; Cunny, G.D.; Hauske, J.R. Potent In vitro methicillin-resistant Staphylococcus aureus activity of 2-(1H-indol-3-yl)quinoline derivatives. Bioorg. Med. Chem. Lett. 2000, 10, 2675–2678. [Google Scholar] [CrossRef]
  14. Birkinshaw, T.N.; Teague, S.J.; Beech, C.; Bonnert, R.V.; Hill, S.; Patel, A.; Reakes, S.; Sanganee, H.; Dougall, I.G.; Phillips, T.T.; et al. Discovery of potent CRTh2 (DP2) receptor antagonists. Bioorg. Med. Chem. Lett. 2006, 16, 4287–4290. [Google Scholar] [CrossRef] [PubMed]
  15. Kuriyama, M.; Matsuo, S.; Shinozawa, M.; Onomura, O. Ether-Imidazolium Carbenes for Suzuki–Miyaura Cross-Coupling of Heteroaryl Chlorides with Aryl/Heteroarylboron Reagents. Org. Lett. 2013, 15, 2716–2719. [Google Scholar] [CrossRef] [PubMed]
  16. Kumar, K.S.; Kumar, S.K.; Sreenivas, B.Y.; Gorja, D.R.; Kapavarapu, R.; Rambabu, D.; Krishna, G.R.; Reddy, C.M.; Rao, M.V.B.; Parsa, K.V.L.; Pal, M. C–C bond formation at C-2 of a quinoline ring: Synthesis of 2-(1H-indol-3-yl)quinoline-3-carbonitrile derivatives as a new class of PDE4 inhibitors. Bioorg. Med. Chem. 2012, 20, 2199–2207. [Google Scholar] [CrossRef] [PubMed]
  17. Brasse, M.; Ellman, J.A.; Bergman, R.G. A facile, metal- and solvent-free, autoxidative coupling of quinolones with indoles and pyrroles. Chem. Commun. 2011, 5019–5021. [Google Scholar] [CrossRef] [PubMed]
  18. Mahato, S.B.; Mandal, N.B.; Chattopadhyay, S.; Nandia, G.; Luger, P.; Weber, M. Synthesis of indolylquinolines under Friedel-Crafts reaction conditions. Tetrahedron 1994, 50, 10803–10812. [Google Scholar] [CrossRef]
  19. Khalafi-Nezhad, A.; Sarikhani, S.; Shahidzadeh, E.S.; Panahi, F. L-Proline-promoted three-component reaction of anilines, aldehydes and barbituric acids/malononitrile: Regioselective synthesis of 5-arylpyrimido[4,5-b]quinoline-diones and 2-amino-4-arylquinoline-3-carbonitriles in water. Green Chem. 2012, 14, 2876–2884. [Google Scholar] [CrossRef]
  20. Kumar, S.; Sahu, D.P. Friedel-Crafts heteroarylation of (hetero)arenes: A facile entry to 4-(hetero)aryl quinazolines and quinolones. J. Hetero. Chem. 2009, 46, 748–755. [Google Scholar] [CrossRef]
  21. Nishida, A.; Miyashita, N.; Fuwa, M.; Nakagawa, M. Synthesis of (3-indolyl)heteroaromatics by suzuki-miyaura coupling and their inhibitory activity in lipid peroxidation. Heterocycles 2003, 59, 473–476. [Google Scholar] [CrossRef]
  22. Ciattini, P.G.; Morera, E.; Ortar, G. An efficient synthesis of 3-substituted indoles by palladium-catalyzed coupling reaction of 3-tributylstannylindoles with organic triflates and halides. Tetrahedron Lett. 1994, 35, 2405–2408. [Google Scholar] [CrossRef]
  23. Arcadi, A.; Chiarini, M.; Marinelli, F.; Picchini, S. A Concise One-Pot Approach to the Synthesis of 4-(1H-Indol-3-yl)quinolones. Synthesis 2011, 4084–4090. [Google Scholar]
  24. Zanwar, M.R.; Gawande, S.D.; Kavala, V.; Kuo, C.-W.; Yao, C.-F. Iron(III) Chloride Catalyzed Synthesis of Highly Substituted Indolyl-Tetrahydroquinoline Derivatives by Using Indolylnitroalkene as Dienophiles and Its Application to the Synthesis of Indolo-Benzonaphthyridine Derivatives. Adv. Synth. Catal. 2014, 356, 3849–3860. [Google Scholar] [CrossRef]
  25. Rajawinslin, R.R.; Ichake, S.S.; Kavala, V.; Gawande, S.D.; Huang, Y.-H.; Kuo, C.-W.; Yao, C.-F. Iron/acetic acid mediated synthesis of 6, 7-dihydrodibenzo [b, j][1,7] phenanthroline derivatives via intramolecular reductive cyclization. RSC Adv. 2015, 5, 52141–52153. [Google Scholar] [CrossRef]
  26. Rajawinslin, R.R.; Gawande, S.D.; Kavala, V.; Huang, Y.-H.; Kuo, C.-W.; Kuo, T.-S.; Chen, M.-L.; He, C.-H.; Yao, C.-F. Iron/acetic acid mediated intermolecular tandem C–C and C–N bond formation: an easy access to acridinone and quinoline derivatives. RSC Adv. 2014, 4, 37806–37811. [Google Scholar] [CrossRef]
  27. Ramesh, C.; Lei, P.M.; Janreddy, D.; Kavala, V.; Kuo, C.-W.; Yao, C.-F. Synthesis of Indolylquinolines, Indolylacridines, and Indolylcyclopenta[b]quinolines from the Baylis–Hillman Adducts: An in Situ [1,3]-Sigmatropic Rearrangement of an Indole Nucleus to Access Indolylacridines and Indolylcyclopenta[b]quinolones. J. Org. Chem. 2012, 77, 8451–8464. [Google Scholar] [CrossRef] [PubMed]
  28. Janreddy, D.; Kavala, V.; Bosco, J.W.; Kuo, C.-W.; Yao, C.-F. An Easy Access to Carbazolones and 2,3-Disubstituted Indoles. Eur. J. Org. Chem. 2011, 2360–2365. [Google Scholar] [CrossRef]
  29. Ramesh, C.; Raju, B.R.; Kavala, V.; Kuo, C.-W.; Yao, C.-F. A simple and facile route for the synthesis of 2H-1,4-benzoxazin-3-(4H)-ones via reductive cyclization of 2-(2-nitrophenoxy) acetonitrile adducts in the presence of Fe/acetic acid. Tetrahedron 2011, 67, 1187–1192. [Google Scholar] [CrossRef]
  30. Ramesh, C.; Kavala, V.; Kuo, C.-W.; Raju, B.R.; Yao, C.-F. An Unprecedented Route for the Synthesis of 3, 3′-Biindoles by Reductive Cyclization of 3-[2-Nitro-1-(2-nitrophenyl)ethyl]-1H-indoles Mediated by Iron/Acetic Acid. Eur. J. Org. Chem. 2010, 3796–3801. [Google Scholar] [CrossRef]
  31. Ramesh, C.; Kavala, V.; Raju, B.R.; Kuo, C.-W.; Yao, C.-F. A simple and facile route for the synthesis of 2H-1, 4-benzoxazin-3-(4H)-ones via reductive cyclization of 2-(2-nitrophenoxy) acetonitrile adducts in the presence of Fe/acetic acid. Tetrahedron Lett. 2010, 51, 5234–5237. [Google Scholar] [CrossRef]
  32. Ramesh, C.; Kavala, V.; Raju, B.R.; Kuo, C.-W.; Yao, C.-F. Novel synthesis of indolylquinoline derivatives via the C-alkylation of Baylis–Hillman adducts. Tetrahedron Lett. 2009, 50, 4037–4041. [Google Scholar] [CrossRef]
  33. Lee, K.Y.; Lee, Y.; Kim, J.N. Synthesis of β,γ-Disubstituted α-Methylene-γ-butyrolactams Starting from the Baylis-Hillman Adducts. Bull. Korean Chem. Soc. 2007, 28, 143–146. [Google Scholar] [CrossRef]
  34. Basavaiah, D.; Rao, J.S.; Raju, J. Simple, Facile, and One-Pot Conversion of the Baylis−Hillman Adducts into Functionalized 1,2,3,4-Tetrahydroacridines and Cyclopenta[b]quinolones. J. Org. Chem. 2004, 69, 7379–7382. [Google Scholar] [CrossRef] [PubMed]
  35. Jonsson, S.; Arribas, C.S.; Wendt, O.F.; Siegel, J.S.; Warnmark, K. Synthesis of 2-pyridone-fused 2,2′-bipyridine derivatives. An unexpectedly complex solid state structure of 3,6-dimethyl-9H-4,5,9-triazaphenanthren-10-one. Org. Biomol. Chem. 2005, 3, 996–1001. [Google Scholar] [CrossRef] [PubMed]
  36. Basavaiah, D.; Raju, J.; Rao, J.S. Applications of Baylis–Hillman adducts: a simple, convenient, and one-pot synthesis of 3-benzoylquinolines. Tetrahedron Lett. 2006, 47, 73–77. [Google Scholar] [CrossRef]
  37. Mahmoudi, A.; Jafari, A.S.; Saeedi, H. Firouzabadi Sulfonic acid-functionalized magnetic nanoparticles as a recyclable and eco-friendly catalyst for atom economical Michael addition reactions and bis indolyl methane synthesis. RSC Adv. 2015, 5, 3023–3030. [Google Scholar] [CrossRef]
  38. Li, S.-S.; Lin, H.; Zhanga, X.-M.; Dong, L. Ruthenium-catalyzed direct C3 alkylation of indoles with α,β-unsaturated ketones. Org. Biomol. Chem. 2015, 13, 1254–1263. [Google Scholar] [CrossRef] [PubMed]
  39. Veisi, H.; Maleki, B.; Eshbala, H.; Veisi, H.; Masti, R.; Ashrafi, S.S.; Baghayeri, M. In situ generation of Iron(III) dodecyl sulfate as Lewis acid-surfactant catalyst for synthesis of bis-indolyl, tris-indolyl, Di(bis-indolyl), Tri(bis-indolyl), tetra(bis-indolyl)methanes and 3-alkylated indole compounds in water. RSC Adv. 2014, 4, 30683–30688. [Google Scholar] [CrossRef]
  40. Gohain, M.; Jacobs, J.; Marais, C.; Bezuidenhoudt, B.C.B. Al(OTf)3 Catalysed Friedel-Crafts Michael Type Addition of Indoles to α,β-Unsaturated Ketones with PEG-200 as Recyclable Solvent. Aust. J. Chem. 2013, 66, 1594–1599. [Google Scholar] [CrossRef]
  41. Zhan, Z.-P.; Yang, R.-F.; Lang, K. Samarium triiodide-catalyzed conjugate addition of indoles with electron-deficient olefins. Tetrahedron Lett. 2005, 46, 3859–3862. [Google Scholar] [CrossRef]
  42. Kumar, V.; Kaur, S.; Kumar, S. ZrCl4 catalyzed highly selective and efficient Michael addition of heterocyclic enamines with α,β-unsaturated olefins. Tetrahedron Lett. 2006, 47, 7001–7005. [Google Scholar] [CrossRef]
  43. Yin, P.; Liu, N.; Deng, Y.-X.; Chen, Y.; Deng, Y.; He, L. Synthesis of 2,4-Diaminoquinazolines and Tricyclic Quinazolines by Cascade Reductive Cyclization of Methyl N-Cyano-2-nitrobenzimidates. J. Org. Chem. 2012, 77, 2649–2658. [Google Scholar] [CrossRef] [PubMed]
  44. Sandelier, M.J.; Shong, P.D. Reductive Cyclization of O-Nitrophenyl Propargyl Alcohols:  Facile Synthesis of Substituted Quinolines. Org. Lett. 2007, 9, 3209–3212. [Google Scholar] [CrossRef] [PubMed]
  • Sample Availability: Samples of the compounds 3a3v, 4a4u are available from the authors.

Share and Cite

MDPI and ACS Style

Chen, W.-C.; Lin, C.-C.; Kavala, V.; Kuo, C.-W.; Huang, C.-Y.; Yao, C.-F. Syntheses of 4-Indolylquinoline Derivatives via Reductive Cyclization of Indolylnitrochalcone Derivatives by Fe/HCl. Molecules 2015, 20, 22499-22519. https://doi.org/10.3390/molecules201219862

AMA Style

Chen W-C, Lin C-C, Kavala V, Kuo C-W, Huang C-Y, Yao C-F. Syntheses of 4-Indolylquinoline Derivatives via Reductive Cyclization of Indolylnitrochalcone Derivatives by Fe/HCl. Molecules. 2015; 20(12):22499-22519. https://doi.org/10.3390/molecules201219862

Chicago/Turabian Style

Chen, Wen-Chang, Chan-Chieh Lin, Veerababurao Kavala, Chun-Wei Kuo, Chia-Yu Huang, and Ching-Fa Yao. 2015. "Syntheses of 4-Indolylquinoline Derivatives via Reductive Cyclization of Indolylnitrochalcone Derivatives by Fe/HCl" Molecules 20, no. 12: 22499-22519. https://doi.org/10.3390/molecules201219862

APA Style

Chen, W. -C., Lin, C. -C., Kavala, V., Kuo, C. -W., Huang, C. -Y., & Yao, C. -F. (2015). Syntheses of 4-Indolylquinoline Derivatives via Reductive Cyclization of Indolylnitrochalcone Derivatives by Fe/HCl. Molecules, 20(12), 22499-22519. https://doi.org/10.3390/molecules201219862

Article Metrics

Back to TopTop